{"data":{"filter_options":{"titles":[{"name":"Managing Partner Atlanta Office","value":"Managing Partner Atlanta Office"},{"name":"Partner","value":"Partner"},{"name":"Partner / Head of Pro Bono","value":"Partner / Head of Pro Bono"},{"name":"Partner / Chief Operating Officer","value":"Partner / Chief Operating Officer"},{"name":"Partner / General Counsel","value":"Partner / General Counsel"},{"name":"Partner / Dir. E-Discovery Ops","value":"Partner / Dir. E-Discovery Ops"},{"name":"Partner / Chairman, Saudi Arabia Practice","value":"Partner / Chairman, Saudi Arabia Practice"},{"name":"K\u0026S Talent Partner","value":"K\u0026S Talent Partner"},{"name":"Partner / Chief Human Resources Officer","value":"Partner / Chief Human Resources Officer"},{"name":"Chairman","value":"Chairman"},{"name":"Senior Counsel","value":"Senior Counsel"},{"name":"Associate Director, E-Discovery Operations","value":"Associate Director, E-Discovery Operations"},{"name":"Counsel","value":"Counsel"},{"name":"Senior Associate","value":"Senior Associate"},{"name":"Associate","value":"Associate"},{"name":"Senior Attorney","value":"Senior Attorney"},{"name":"Senior Lawyer","value":"Senior Lawyer"},{"name":"Attorney","value":"Attorney"},{"name":"Senior Counsel and Policy Advisor","value":"Senior Counsel and Policy Advisor"},{"name":"Managing Director - Capital Solutions","value":"Managing Director - Capital Solutions"},{"name":"Senior Government Relations Advisor","value":"Senior Government Relations Advisor"},{"name":"Associate General Counsel","value":"Associate General Counsel"},{"name":"Senior Advisor","value":"Senior Advisor"},{"name":"Patent Agent","value":"Patent Agent"},{"name":"Consultant","value":"Consultant"},{"name":"Government Relations Advisor","value":"Government Relations Advisor"},{"name":"Chief of Lateral Partner Recruiting \u0026 Integration","value":"Chief of Lateral Partner Recruiting \u0026 Integration"},{"name":"Chief Financial Officer","value":"Chief Financial Officer"},{"name":"Chief Information Officer","value":"Chief Information Officer"},{"name":"Chief Revenue Officer","value":"Chief Revenue Officer"},{"name":"Chief Recruiting Officer","value":"Chief Recruiting Officer"},{"name":"Chief Lawyer Talent Development Officer","value":"Chief Lawyer Talent Development Officer"},{"name":"Chief Marketing Officer","value":"Chief Marketing Officer"},{"name":"Tax Consultant","value":"Tax Consultant"},{"name":"Director of Community Affairs","value":"Director of Community Affairs"},{"name":"Director of Facilities \u0026 Admin Operations","value":"Director of Facilities \u0026 Admin Operations"},{"name":"Senior Office Manager","value":"Senior Office Manager"},{"name":"Director of Operations","value":"Director of Operations"},{"name":"Pro Bono Deputy","value":"Pro Bono Deputy"},{"name":"Director of Office Operations","value":"Director of Office Operations"},{"name":"Director of Operations Europe","value":"Director of Operations Europe"},{"name":"Law Clerk","value":"Law Clerk"},{"name":"Deputy General Counsel","value":"Deputy General Counsel"}],"schools":[{"name":"(Commercial Law), in front of Monash University, Australia","value":3045},{"name":"Aberystwyth University","value":3004},{"name":"Albany Law School","value":2118},{"name":"American University Washington College of Law","value":3042},{"name":"American University, Washington College of Law","value":3024},{"name":"Appalachian School of Law","value":2891},{"name":"Ateneo de Manila University","value":2914},{"name":"Ave Maria School of Law","value":2892},{"name":"Baylor University School of Law","value":181},{"name":"Benjamin N. Cardozo School of Law","value":2619},{"name":"Binghamton University","value":3002},{"name":"Boston College Law School","value":245},{"name":"Boston University School of Law","value":247},{"name":"BPP Law School Leeds","value":2642},{"name":"BPP Law School London","value":2782},{"name":"BPP University","value":2984},{"name":"Brooklyn Law School","value":2705},{"name":"Cairo University, Law School","value":2962},{"name":"California Western School of Law","value":315},{"name":"Capital University Law School","value":327},{"name":"Case Western Reserve University School of Law","value":345},{"name":"Cecil C. Humphreys School of Law","value":2235},{"name":"Chapman University School of Law","value":377},{"name":"Charleston School of Law","value":2910},{"name":"City Law School, London","value":2998},{"name":"City Law School","value":2857},{"name":"Clark University","value":3006},{"name":"Cleveland-Marshall College of Law","value":426},{"name":"Columbia University School of International and Public Affairs","value":3008},{"name":"Columbia University School of Law","value":485},{"name":"Columbia University","value":3126},{"name":"Columbus School of Law, Catholic University of America","value":3010},{"name":"Columbus School of Law","value":350},{"name":"Concord Law School of Kaplan University","value":1026},{"name":"Cornell Law School","value":512},{"name":"Creighton University School of Law","value":518},{"name":"Creighton University","value":3025},{"name":"Cumberland School of Law","value":1759},{"name":"CUNY School of Law","value":2893},{"name":"David A. Clarke School of Law","value":2399},{"name":"Deakin University School of Law","value":2907},{"name":"DePaul University College of Law","value":565},{"name":"DePaul University College of Law","value":3060},{"name":"Dickinson School of Law","value":2719},{"name":"Drake University Law School","value":609},{"name":"Duke University School of Law","value":613},{"name":"Duquesne University School of Law","value":614},{"name":"Dwayne O. Andreas School of Law","value":173},{"name":"Edinburgh Law School","value":3160},{"name":"Emory University School of Law","value":659},{"name":"ESADE Business and Law School – Universidad Ramon Llull","value":3215},{"name":"Fachseminare von Fürstenberg","value":2918},{"name":"Faculté Libre de Droit, Université Catholique de Lille","value":3055},{"name":"Faculty of Law, University of Zagreb","value":2983},{"name":"Faculty of Law","value":2944},{"name":"Faculty of Law","value":3039},{"name":"Federal University of Rio de Janeiro","value":3022},{"name":"Federal University of Rio Grande do Sul School of Law (Brazil)","value":3062},{"name":"Florida A\u0026M University College of Law","value":699},{"name":"Florida Coastal School of Law","value":2894},{"name":"Florida International College of Law","value":707},{"name":"Florida State University College of Law","value":720},{"name":"Fordham University School of Law","value":722},{"name":"Franklin Pierce Law Center","value":734},{"name":"Friedrich-Schiller-Universität Jena","value":3015},{"name":"George Mason University School of Law","value":752},{"name":"George Washington University Law School","value":753},{"name":"Georgetown University Law Center","value":755},{"name":"Georgia State University College of Law","value":761},{"name":"Ghent Law School","value":2793},{"name":"Golden Gate University School of Law","value":770},{"name":"Gonzaga University School of Law","value":772},{"name":"Graduate Institute of International and Development Studies, Geneva","value":2997},{"name":"Hamline University School of Law","value":811},{"name":"Harvard Law School","value":824},{"name":"Hebrew University of Jerusalem Faculty of Law","value":2994},{"name":"Hofstra University School of Law","value":858},{"name":"Howard University School of Law","value":872},{"name":"Huazhong University of Science and Technology","value":3016},{"name":"Humboldt University of Berlin","value":3012},{"name":"Indiana University School of Law","value":2711},{"name":"Indiana University School of Law","value":890},{"name":"International Association of Privacy Professionals","value":3009},{"name":"J. Reuben Clark Law School","value":262},{"name":"Jacob D. Fuchsberg Law Center","value":2084},{"name":"James Cook University of North Queensland","value":3034},{"name":"Jean Moulin University Lyon 3, France","value":2938},{"name":"Johns Hopkins Bloomberg School of Public Health","value":2992},{"name":"Justus-Liebig-Universität Gießen Rechtswissenschaft (Germany)","value":3063},{"name":"Kansas City School of Law","value":2247},{"name":"Keio University","value":2968},{"name":"Kent College of Law","value":883},{"name":"Kline School of Law","value":611},{"name":"KU Leuven","value":3007},{"name":"Levin College of Law","value":2189},{"name":"Lewis and Clark Law School","value":1089},{"name":"Liberty University School of Law","value":1094},{"name":"Lincoln College of Law","value":2253},{"name":"LL.M. in International Crime and Justice UNICRI","value":2937},{"name":"Loyola Law School","value":2895},{"name":"Loyola University Chicago School of Law","value":1135},{"name":"Loyola University New Orleans College of Law","value":1136},{"name":"Marquette University Law School","value":1176},{"name":"McGeorge School of Law","value":2402},{"name":"McGill University","value":2659},{"name":"Melbourne Law School","value":2899},{"name":"Mercer University Walter F. George School of Law","value":1221},{"name":"Mexico Autonomous Institute of Technology","value":2996},{"name":"Michael E. Moritz College of Law","value":2728},{"name":"Michigan State University College of Law","value":1245},{"name":"Mississippi College School of Law","value":1285},{"name":"Moscow State University","value":2815},{"name":"National and Kapodistrian University of Athens","value":3032},{"name":"National Law University Jodhpur","value":3020},{"name":"National University of Singapore, Faculty of Law","value":2662},{"name":"New England School of Law","value":2886},{"name":"New York Law School","value":1403},{"name":"New York University School of Law","value":1406},{"name":"Norman Adrian Wiggins School of Law","value":323},{"name":"North Carolina Central University School of Law","value":1417},{"name":"Northeastern University School of Law","value":1430},{"name":"Northern Illinois University College of Law","value":1432},{"name":"Northwestern Pritzker School of Law","value":1451},{"name":"Notre Dame Law School","value":2278},{"name":"Ohio Northern University Law School","value":3036},{"name":"Oklahoma City University School of Law","value":1487},{"name":"Osgoode Hall Law School","value":3124},{"name":"Pace University School of Law","value":1516},{"name":"Panteion University","value":3033},{"name":"Paul M. Hebert Law Center","value":2713},{"name":"Pennsylvania State University, Dickinson School of Law","value":1562},{"name":"Pepperdine University School of Law","value":1570},{"name":"Pettit College of Law","value":1473},{"name":"Pontificia Universidad Catolica de Chile","value":3203},{"name":"Pontificia Universidad Catolica del Peru","value":3011},{"name":"Pontificia Universidad Javeriana","value":3013},{"name":"Pontificia Universidade Catolica de Sao Paulo","value":3095},{"name":"Prince Sultan University College of Law","value":3167},{"name":"Queens College, Cambridge","value":3003},{"name":"Quinnipiac University School of Law","value":1626},{"name":"Ralph R. Papitto School of Law","value":1686},{"name":"Regent University School of Law","value":1649},{"name":"Rice University","value":3043},{"name":"Ruprecht-Karls-Universität Heidelberg","value":3049},{"name":"Rutgers University School of Law-Newark","value":1699},{"name":"Rutgers University School of Law","value":1697},{"name":"S.J. Quinney College of Law","value":2408},{"name":"Saint Louis University School of Law","value":1732},{"name":"Salmon P. Chase College of Law","value":1433},{"name":"Sandra Day O'Connor College of Law","value":103},{"name":"Santa Clara University School of Law","value":1771},{"name":"Seattle University School of Law","value":1787},{"name":"Seton Hall University School of Law","value":1790},{"name":"Shepard Broad Law Center","value":1460},{"name":"South Texas College of Law","value":2721},{"name":"Southern Illinois University School of Law","value":1849},{"name":"Southern Methodist University Dedman School of Law","value":1852},{"name":"Southern University Law Center","value":1857},{"name":"Southwestern Law School","value":1876},{"name":"St. John's University School of Law","value":2724},{"name":"St. Mary's University School of Law","value":1896},{"name":"St. Thomas University School of Law","value":1746},{"name":"Stanford Law School","value":1904},{"name":"Stetson University College of Law","value":1910},{"name":"Sturm College of Law","value":2184},{"name":"Suffolk University Law School","value":1921},{"name":"Syracuse University College of Law","value":1956},{"name":"Temple University Beasley School of Law","value":1974},{"name":"Texas A\u0026M School of Law","value":1980},{"name":"Texas Tech University School of Law","value":1994},{"name":"Texas Wesleyan University School of Law","value":1996},{"name":"The College of Law Australia","value":3091},{"name":"The College of Law, London","value":2935},{"name":"The John Marshall Law School","value":2034},{"name":"The Judge Advocate General's Legal Center and School","value":2896},{"name":"The Ohio State University Moritz College of Law","value":2990},{"name":"The University of Akron School of Law","value":2143},{"name":"The University of Alabama School of Law","value":2045},{"name":"The University of Birmingham, U.K.","value":2796},{"name":"The University of Iowa College of Law","value":2206},{"name":"The University of Texas School of Law","value":2055},{"name":"The University of Tulsa College of Law","value":2407},{"name":"Thomas Jefferson School of Law","value":685},{"name":"Thomas M. Cooley Law School","value":2729},{"name":"Thurgood Marshall School of Law","value":1992},{"name":"Tianjin University of Commerce","value":2995},{"name":"Tulane University Law School","value":2113},{"name":"UC Davis School of Law","value":2160},{"name":"UCLA School of Law","value":2162},{"name":"Universidad Católica de Honduras","value":2916},{"name":"Universidad Francisco Marroquin","value":3090},{"name":"Universidad Panamericana","value":2904},{"name":"Universidad Torcuato di Tella","value":3035},{"name":"Universidade de São Paulo, Faculdade de Direito","value":3028},{"name":"Universidade Presbiteriana Mackenzie","value":2977},{"name":"Università Commerciale Luigi Bocconi","value":3135},{"name":"University at Buffalo Law School","value":1928},{"name":"University College Dublin Law School","value":2900},{"name":"University of Alberta Faculty of Law","value":3088},{"name":"University of Amsterdam","value":2980},{"name":"University of Arizona, James E. Rogers College of Law","value":2149},{"name":"University of Arkansas School of Law","value":2154},{"name":"University of Baltimore School of Law","value":2156},{"name":"University of California College of the Law","value":3196},{"name":"University of California Hastings College of Law","value":2158},{"name":"University of California Irvine School of Law","value":2161},{"name":"University of California, Berkeley, School of Law","value":2159},{"name":"University of California, Davis","value":3019},{"name":"University of Cambridge, U.K","value":2991},{"name":"University of Canterbury","value":2981},{"name":"University of Central Florida","value":3027},{"name":"University of Chester Law School","value":3005},{"name":"University of Chicago Law School","value":2174},{"name":"University of Chicago","value":3038},{"name":"University of Cincinnati College of Law","value":2175},{"name":"University of Colorado School of Law","value":2177},{"name":"University of Connecticut School of Law","value":2180},{"name":"University of Dayton School of Law","value":2182},{"name":"University of Detroit Mercy School of Law","value":2185},{"name":"University of East Anglia","value":3000},{"name":"University of Florida, Levin College of Law","value":3188},{"name":"University of Georgia School of Law","value":2190},{"name":"University of Houston Law Center","value":2197},{"name":"University of Hull","value":3040},{"name":"University of Idaho College of Law","value":2201},{"name":"University of Illinois College of Law","value":2204},{"name":"University of Kansas School of Law","value":2208},{"name":"University of Kentucky College of Law","value":2210},{"name":"University of La Verne College of Law","value":2211},{"name":"University of Law, London","value":2999},{"name":"University of Lethbridge","value":3030},{"name":"University of Louisville Brandeis School of Law","value":2214},{"name":"University of Maine School of Law","value":2391},{"name":"University of Maryland School of Law","value":2224},{"name":"University of Miami School of Law","value":2236},{"name":"University of Michigan Law School","value":2237},{"name":"University of Minnesota Law School","value":2243},{"name":"University of Mississippi School of Law","value":2244},{"name":"University of Missouri School of Law","value":2246},{"name":"University of Montana School of Law","value":2048},{"name":"University of Nebraska College of Law","value":2744},{"name":"University of New Mexico School of Law","value":2262},{"name":"University of North Carolina School of Law","value":2266},{"name":"University of North Dakota School of Law","value":2271},{"name":"University of Oklahoma Law Center","value":2747},{"name":"University of Oregon School of Law","value":2281},{"name":"University of Pennsylvania Law School","value":2282},{"name":"University of Pittsburgh School of Law","value":2354},{"name":"University of Richmond School of Law","value":2370},{"name":"University of San Diego School of Law","value":2377},{"name":"University of San Francisco School of Law","value":2378},{"name":"University of South Carolina School of Law","value":2750},{"name":"University of South Dakota School of Law","value":2387},{"name":"University of Southern California Gould School of Law","value":3051},{"name":"University of St. Thomas School of Law","value":2751},{"name":"University of Sydney Law School","value":3031},{"name":"University of Tennessee College of Law","value":2051},{"name":"University of the West of England, Bristol","value":3001},{"name":"University of Toledo College of Law","value":2406},{"name":"University of Toronto","value":2912},{"name":"University of Utah","value":3026},{"name":"University of Virginia School of Law","value":2410},{"name":"University of Washington School of Law","value":2412},{"name":"University of Wisconsin Law School","value":2419},{"name":"University of Wyoming College of Law","value":2429},{"name":"University of Zürich","value":3037},{"name":"University Paris Dauphine","value":2976},{"name":"University Paris II Assas","value":2975},{"name":"University Paris II Assas","value":3052},{"name":"USC Gould School of Law","value":2389},{"name":"Utrecht University","value":3085},{"name":"Valparaiso University School of Law","value":2441},{"name":"Vanderbilt University School of Law","value":2442},{"name":"Vermont Law School","value":2451},{"name":"Villanova University School of Law","value":2454},{"name":"Wake Forest University School of Law","value":2471},{"name":"Washburn University School of Law","value":2482},{"name":"Washington and Lee University School of Law","value":2484},{"name":"Washington College of Law","value":61},{"name":"Washington University in St. Louis School of Law","value":2489},{"name":"Wayne State University Law School","value":2493},{"name":"West Virginia University College of Law","value":2517},{"name":"Western New England College School of Law","value":2528},{"name":"Western State College of Law","value":2897},{"name":"Wharton School of Business","value":3044},{"name":"Whittier Law School","value":2564},{"name":"Widener University Delaware Law School","value":2569},{"name":"Willamette University College of Law","value":2573},{"name":"William \u0026 Mary Law School","value":462},{"name":"William H. Bowen School of Law","value":2150},{"name":"William Mitchell College of Law","value":2758},{"name":"William S. Boyd School of Law","value":2256},{"name":"William S. Richardson School of Law","value":2195},{"name":"Wilmington University","value":2993},{"name":"Yale Law School","value":2605}],"offices":[{"name":"Abu Dhabi","value":13},{"name":"Atlanta","value":1},{"name":"Austin","value":12},{"name":"Brussels","value":23},{"name":"Charlotte","value":8},{"name":"Chicago","value":21},{"name":"Dallas","value":28},{"name":"Denver","value":22},{"name":"Dubai","value":6},{"name":"Frankfurt","value":9},{"name":"Geneva","value":15},{"name":"Houston","value":4},{"name":"London","value":5},{"name":"Los Angeles","value":19},{"name":"Miami","value":25},{"name":"New York","value":3},{"name":"Northern Virginia","value":24},{"name":"Paris","value":14},{"name":"Riyadh","value":27},{"name":"Sacramento","value":20},{"name":"San Francisco","value":10},{"name":"Silicon Valley","value":11},{"name":"Singapore","value":16},{"name":"Sydney","value":26},{"name":"Tokyo","value":18},{"name":"Washington, D.C.","value":2}],"capabilities":[{"name":"Corporate, Finance and Investments","value":"cg-1"},{"name":"Activist Defense","value":72},{"name":"Capital Markets","value":26},{"name":"Construction and Procurement","value":40},{"name":"Corporate Governance","value":27},{"name":"Emerging Companies and Venture Capital","value":80},{"name":"Employee Benefits and Executive Compensation","value":28},{"name":"Energy and Infrastructure Projects","value":35},{"name":"Financial Restructuring","value":10},{"name":"Fund Finance","value":134},{"name":"Global Human Capital and Compliance ","value":121},{"name":"Investment Funds and Asset Management","value":78},{"name":"Leveraged Finance","value":29},{"name":"Mergers and Acquisitions (M\u0026A)","value":32},{"name":"Middle East and Islamic Finance and Investment","value":31},{"name":"Private Equity","value":33},{"name":"Public Companies","value":126},{"name":"Real Estate","value":36},{"name":"Structured Finance and Securitization","value":82},{"name":"Tax","value":37},{"name":"Technology Transactions","value":115},{"name":"Government Matters","value":"cg-2"},{"name":"Antitrust","value":1},{"name":"Data, Privacy and Security","value":6},{"name":"Environmental, Health and Safety","value":71},{"name":"FDA and Life Sciences","value":21},{"name":"Government Advocacy and Public Policy","value":23},{"name":"Government Contracts","value":116},{"name":"Healthcare","value":24},{"name":"Innovation Protection","value":135},{"name":"International Trade","value":25},{"name":"National Security and Corporate Espionage","value":110},{"name":"Securities Enforcement and Regulation","value":20},{"name":"Special Matters and Government Investigations","value":11},{"name":"Trial and Global Disputes","value":"cg-3"},{"name":"Antitrust ","value":129},{"name":"Appellate, Constitutional and Administrative Law","value":2},{"name":"Bankruptcy and Insolvency Litigation","value":38},{"name":"Class Action Defense","value":3},{"name":"Commercial Litigation","value":5},{"name":"Corporate and Securities Litigation","value":19},{"name":"E-Discovery","value":7},{"name":"Global Construction and Infrastructure Disputes","value":4},{"name":"Innovation Protection","value":136},{"name":"Intellectual Property","value":13},{"name":"International Arbitration and Litigation","value":14},{"name":"Labor and Employment","value":15},{"name":"Product Liability","value":17},{"name":"Professional Liability","value":18},{"name":"Toxic \u0026 Environmental Torts","value":16},{"name":"Industries / Issues","value":"cg-4"},{"name":"Artificial Intelligence (AI) and Machine Learning","value":133},{"name":"Automotive, Transportation and Mobility","value":106},{"name":"Buy American","value":124},{"name":"Crisis Management","value":111},{"name":"Doing Business in Latin America","value":132},{"name":"Energy Transition","value":131},{"name":"Energy","value":102},{"name":"Environmental Agenda","value":125},{"name":"Environmental, Social and Governance (ESG)","value":127},{"name":"Financial Services","value":107},{"name":"Focus on Women's Health","value":112},{"name":"Food and Beverage","value":105},{"name":"Higher Education","value":109},{"name":"Life Sciences and Healthcare","value":103},{"name":"Russia/Ukraine","value":128},{"name":"Special Purpose Acquisition Companies (SPACs)","value":123},{"name":"Technology","value":118}]},"title_id":null,"school_id":null,"office_id":null,"capability_id":"103","extra_filter_id":null,"extra_filter_type":null,"q":null,"starts_with":"Z","per_page":12,"people":[{"id":446328,"version":1,"owner_type":"Person","owner_id":5909,"payload":{"bio":"\u003cp\u003eRick Zall is a partner and chair of King \u0026amp; Spalding\u0026rsquo;s healthcare transactional and regulatory practice. He represents clients on both transactional and regulatory healthcare matters, including advising healthcare operating companies, private equity investors and lenders on M\u0026amp;A, joint ventures, financings and complex commercial transactions. He advises on state and federal healthcare regulatory compliance matters, including navigating fraud and abuse and corporate practice of medicine prohibitions, Medicare and Medicaid payment rules.\u0026nbsp;Rick also counsels clients in the emerging digital health and health information technology sectors on compliance with data privacy and security laws, telemedicine licensure regulations and health benefit management.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eWith deep experience in the healthcare industry, Rick is known for practical and effective solutions to successfully structure, negotiate and close deals for his clients.\u003c/p\u003e\n\u003cp\u003eRick advises clients on regulatory compliance matters including fraud and abuse, corporate practice of medicine, structuring physician incentive arrangements, digital health/telemedicine, HIPAA, Medicare/Medicaid reimbursement and value-based payments.\u003c/p\u003e\n\u003cp\u003ePrior to joining King \u0026amp; Spalding, Rick was a partner and the chairman of the healthcare practice for an\u0026nbsp;\u003cem\u003eAm Law 100\u003c/em\u003e\u0026nbsp;firm.\u003c/p\u003e","slug":"richard-zall","email":"rzall@kslaw.com","phone":null,"matters":["\u003cp\u003eRepresented Accuity Delivery Systems in its sale to an affiliate of private equity firm, Frazier Healthcare Partners.\u003c/p\u003e","\u003cp\u003eRepresented Apnicure, a healthcare technology and medical device company, in connection with regulatory compliance state telemedicine laws and corporate structuring.\u003c/p\u003e","\u003cp\u003eRepresented Archimedes Health Investors and its portfolio company, National Partners in Health, in connection with the acquisition of Waxahachie Anaesthesia Consultants, National Medical Billing Management, Anaesthesia Resources, and TAMI and their related physician billing and practice management companies.\u003c/p\u003e","\u003cp\u003eRepresented Ares Management LLC, as special healthcare counsel in its acquisitions of both OB Hospitalist Group and Unified Physician Management.\u003c/p\u003e","\u003cp\u003eRepresented Ascension Health and it\u0026rsquo;s Our Lady of Lourdes Memorial Hospital in Binghamton, New York in its sale to The Guthrie Clinic.\u003c/p\u003e","\u003cp\u003eRepresented Bain Capital Ventures in its investment in Strategic Pharmaceutical Solutions, d/b/a Vetsource, an institutional pharmacy that dispenses prescription products to veterinarians and animal hospitals.\u003c/p\u003e","\u003cp\u003eRepresented The Brooklyn Hospital Center in the establishment of ModernMD, an urgent care joint venture with Blue Wolf Capital.\u003c/p\u003e","\u003cp\u003eRepresented Cambia Health in the establishment of a joint venture platform for Cambia (Regence Blue Cross) and Blue Cross/Blue Shield of North Carolina.\u003c/p\u003e","\u003cp\u003eRepresented Cincinnati Eye Institute (CEI) in the launch of CEI Vision Partners, a new management services organization formed with an investment from Revelstoke Capital Partners.\u003c/p\u003e","\u003cp\u003eRepresented Concerto Healthcare in the sale of its affiliated health plan in Michigan to Centene, a publicly traded HMO.\u003c/p\u003e","\u003cp\u003eRepresented Crystal Run Healthcare in the structuring of an ambulatory surgery joint venture with Orange Regional Medical Center.\u003c/p\u003e","\u003cp\u003eRepresented Data Driven Delivery Systems, LLC in its sale to Blue Cross Blue Shield of Michigan.\u003c/p\u003e","\u003cp\u003eRepresented Diana Health, a women\u0026rsquo;s health services company, in its $34.0 million Series B funding round led by Norwest Venture Partners with participation by .406 Ventures, LRV Health, and AlleyCorp.\u003c/p\u003e","\u003cp\u003eRepresented Eleanor Health, an outpatient addiction treatment provider, in its $50.0 million Series C financing, and $30.0 million Series D financing, led by General Catalyst with participation by Town Hall Ventures, Echo Health Ventures, Northpond Ventures, Rethink Impact and Emerson Collective.\u003c/p\u003e","\u003cp\u003eRepresented Healthcare Payment Specialists in their sale to acquirer, Nautic Partners Health Connect in establishing a joint venture between Newport Heath Solutions and Northwell Health to commercialize NHS\u0026rsquo; population health management software.\u003c/p\u003e","\u003cp\u003eRepresented Helena Special Investments as corporate and regulatory counsel which led a $100.0 million Series A investment in Lykos Therapeutics, provider of MDMA-assisted therapy for PTSD. This transaction was challenging since Lykos is a subsidiary of Multidisciplinary Association for Psychedelic Studies (MAPS), a not-for-profit research institution.\u003c/p\u003e","\u003cp\u003eRepresented Jersey City Medical Center in its sale to Robert Wood Johnson/Barnabas Health System.\u003c/p\u003e","\u003cp\u003eRepresented Kayne Anderson Capital Advisors in connection with the New Jersey Department of Health for the change of ownership of an assisted living residence in New Jersey as a liaison between the client and the regulators.\u003c/p\u003e","\u003cp\u003eRepresented Kelsey-Seybold Medical Group in its sale to TPG Capital of a minority interest in its management services company.\u003c/p\u003e","\u003cp\u003eRepresented Kode Health, a tech-enabled medical coding company, in its $22.5 million Series B financing led by Noro-Moseley Partners with participation by FCA Venture Partners and Epsilon Healthcare Investors.\u003c/p\u003e","\u003cp\u003eRepresented Lehigh Valley Health Network in its merger with Jefferson Health creating a $14.0 billion integrated health delivery system in Eastern Pennsylvania.\u003c/p\u003e","\u003cp\u003eRepresented Medical Home Network in connection with counseling on a myriad of U.S. laws, state and federal Stark and anti-kickback laws, regulating healthcare payment and delivery systems, and best practices for distributing shared savings.\u003c/p\u003e","\u003cp\u003eRepresented Medical Home Network in the investment by Oak HC/FT.\u003c/p\u003e","\u003cp\u003eRepresented MEP Health, a Maryland-based physician emergency medicine group, in its merger with U.S. Acute Care Solutions.\u003c/p\u003e","\u003cp\u003eRepresented Mount Sinai Health System in its joint ventures with The Children's Hospital of Philadelphia (CHOP) and National Jewish Health.\u003c/p\u003e","\u003cp\u003eRepresented North Haven Credit Partners in connection with an investment and loan to Code 3, free standing emergency room centers in Texas and Nevada.\u003c/p\u003e","\u003cp\u003eRepresented Northern Westchester Hospital in its strategic health system affiliation with Northwell Health.\u003c/p\u003e","\u003cp\u003eRepresented Richmond University Medical Center in its acquisition of St. Vincent\u0026rsquo;s Staten Island Hospital, and sale of its interest in The Heart Institute to Staten Island University Hospital.\u003c/p\u003e","\u003cp\u003eRepresented Sentinel Capital Partners in their investment in MB2 Dental Solutions, a dental service organization with 85 affiliated practices.\u003c/p\u003e","\u003cp\u003eRepresented Sephardic Nursing and Rehabilitation Center in its sale to Allure, Inc. Solera Capital in the sale of its portfolio company The Little Clinic to the retailer Kroger, Inc.\u003c/p\u003e","\u003cp\u003eRepresented South Nassau Communities Hospital in its acquisition of Long Beach Medical Center.\u003c/p\u003e","\u003cp\u003eRepresented St. Luke\u0026rsquo;s-Roosevelt Hospital Center, Inc. in the spin-off of its outpatient primary care clinics to an affiliate of William F. Ryan Community Health Center, Inc.\u003c/p\u003e","\u003cp\u003eRepresented Teladoc, Inc., in connection with state licensing and regulatory compliance matters.\u003c/p\u003e","\u003cp\u003eRepresented Town Hall Ventures in its co-investment in VillageMD.\u003c/p\u003e","\u003cp\u003eRepresented Virginia Eye Consultants in its sale to CEI Vision Partners.\u003c/p\u003e","\u003cp\u003eRepresented WellBox, Inc. in its establishment of a Medicare chronic care management (CCM).\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[{"id":3789}]},"expertise":[{"id":24,"guid":"24.capabilities","index":0,"source":"capabilities"},{"id":33,"guid":"33.capabilities","index":1,"source":"capabilities"},{"id":32,"guid":"32.capabilities","index":2,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":3,"source":"capabilities"},{"id":112,"guid":"112.capabilities","index":4,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":5,"source":"capabilities"},{"id":826,"guid":"826.smart_tags","index":6,"source":"smartTags"},{"id":1202,"guid":"1202.smart_tags","index":7,"source":"smartTags"},{"id":1261,"guid":"1261.smart_tags","index":8,"source":"smartTags"},{"id":133,"guid":"133.capabilities","index":9,"source":"capabilities"}],"is_active":true,"last_name":"Zall","nick_name":"Rick","clerkships":[],"first_name":"Richard","title_rank":9999,"updated_by":202,"law_schools":[{"id":1406,"meta":{"degree":"J.D.","honors":"Arthur Garfield Hays Fellow","is_law_school":"1","graduation_date":"1980-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"","recognitions":[{"title":"Recognized for leading major transactions, including a $14 billion merger between Lehigh Valley Health Network and Jefferson Health","detail":"Law360 Healthcare MVP, 2024 "},{"title":"Ranked Band 1 for 19 consecutive years for excellence in healthcare transactional and regulatory law","detail":"Chambers USA: New York: Healthcare - 2023–2024 "},{"title":"Top Ranked Lawyer, Healthcare","detail":"Chambers USA, New York (2006-2022)"},{"title":"\"He is extremely knowledgeable and thoughtful...leaves no stone unturned...He is top of his field in healthcare law.\" ","detail":"Chambers USA (2022)"},{"title":"The Best Lawyers in America: Health Care Law","detail":"29th Edition, 2022"},{"title":"Chambers USA: Nationwide: Healthcare: Transactional","detail":"2012-2020"},{"title":"The Legal 500 United States: Healthcare \u0026 Life Sciences: Healthcare","detail":"2011"},{"title":"The Legal 500 United States: Healthcare: Service Providers","detail":"2013-2014, 2016-2020"},{"title":"Best Lawyers in America","detail":"1991-2021, 2025"},{"title":"New York Super Lawyers","detail":"2006-2020"},{"title":"Fellow","detail":"The New York Academy of Medicine"},{"title":"“Outstanding Healthcare Transaction Lawyer,” ","detail":"Nightingale’s Healthcare News"}],"linked_in_url":null,"seodescription":"Richard Zall (Rick) is a lawyer of our Government Matters \u0026 Regulation Practice Group. Read more.","primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eRick Zall is a partner and chair of King \u0026amp; Spalding\u0026rsquo;s healthcare transactional and regulatory practice. He represents clients on both transactional and regulatory healthcare matters, including advising healthcare operating companies, private equity investors and lenders on M\u0026amp;A, joint ventures, financings and complex commercial transactions. He advises on state and federal healthcare regulatory compliance matters, including navigating fraud and abuse and corporate practice of medicine prohibitions, Medicare and Medicaid payment rules.\u0026nbsp;Rick also counsels clients in the emerging digital health and health information technology sectors on compliance with data privacy and security laws, telemedicine licensure regulations and health benefit management.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eWith deep experience in the healthcare industry, Rick is known for practical and effective solutions to successfully structure, negotiate and close deals for his clients.\u003c/p\u003e\n\u003cp\u003eRick advises clients on regulatory compliance matters including fraud and abuse, corporate practice of medicine, structuring physician incentive arrangements, digital health/telemedicine, HIPAA, Medicare/Medicaid reimbursement and value-based payments.\u003c/p\u003e\n\u003cp\u003ePrior to joining King \u0026amp; Spalding, Rick was a partner and the chairman of the healthcare practice for an\u0026nbsp;\u003cem\u003eAm Law 100\u003c/em\u003e\u0026nbsp;firm.\u003c/p\u003e","matters":["\u003cp\u003eRepresented Accuity Delivery Systems in its sale to an affiliate of private equity firm, Frazier Healthcare Partners.\u003c/p\u003e","\u003cp\u003eRepresented Apnicure, a healthcare technology and medical device company, in connection with regulatory compliance state telemedicine laws and corporate structuring.\u003c/p\u003e","\u003cp\u003eRepresented Archimedes Health Investors and its portfolio company, National Partners in Health, in connection with the acquisition of Waxahachie Anaesthesia Consultants, National Medical Billing Management, Anaesthesia Resources, and TAMI and their related physician billing and practice management companies.\u003c/p\u003e","\u003cp\u003eRepresented Ares Management LLC, as special healthcare counsel in its acquisitions of both OB Hospitalist Group and Unified Physician Management.\u003c/p\u003e","\u003cp\u003eRepresented Ascension Health and it\u0026rsquo;s Our Lady of Lourdes Memorial Hospital in Binghamton, New York in its sale to The Guthrie Clinic.\u003c/p\u003e","\u003cp\u003eRepresented Bain Capital Ventures in its investment in Strategic Pharmaceutical Solutions, d/b/a Vetsource, an institutional pharmacy that dispenses prescription products to veterinarians and animal hospitals.\u003c/p\u003e","\u003cp\u003eRepresented The Brooklyn Hospital Center in the establishment of ModernMD, an urgent care joint venture with Blue Wolf Capital.\u003c/p\u003e","\u003cp\u003eRepresented Cambia Health in the establishment of a joint venture platform for Cambia (Regence Blue Cross) and Blue Cross/Blue Shield of North Carolina.\u003c/p\u003e","\u003cp\u003eRepresented Cincinnati Eye Institute (CEI) in the launch of CEI Vision Partners, a new management services organization formed with an investment from Revelstoke Capital Partners.\u003c/p\u003e","\u003cp\u003eRepresented Concerto Healthcare in the sale of its affiliated health plan in Michigan to Centene, a publicly traded HMO.\u003c/p\u003e","\u003cp\u003eRepresented Crystal Run Healthcare in the structuring of an ambulatory surgery joint venture with Orange Regional Medical Center.\u003c/p\u003e","\u003cp\u003eRepresented Data Driven Delivery Systems, LLC in its sale to Blue Cross Blue Shield of Michigan.\u003c/p\u003e","\u003cp\u003eRepresented Diana Health, a women\u0026rsquo;s health services company, in its $34.0 million Series B funding round led by Norwest Venture Partners with participation by .406 Ventures, LRV Health, and AlleyCorp.\u003c/p\u003e","\u003cp\u003eRepresented Eleanor Health, an outpatient addiction treatment provider, in its $50.0 million Series C financing, and $30.0 million Series D financing, led by General Catalyst with participation by Town Hall Ventures, Echo Health Ventures, Northpond Ventures, Rethink Impact and Emerson Collective.\u003c/p\u003e","\u003cp\u003eRepresented Healthcare Payment Specialists in their sale to acquirer, Nautic Partners Health Connect in establishing a joint venture between Newport Heath Solutions and Northwell Health to commercialize NHS\u0026rsquo; population health management software.\u003c/p\u003e","\u003cp\u003eRepresented Helena Special Investments as corporate and regulatory counsel which led a $100.0 million Series A investment in Lykos Therapeutics, provider of MDMA-assisted therapy for PTSD. This transaction was challenging since Lykos is a subsidiary of Multidisciplinary Association for Psychedelic Studies (MAPS), a not-for-profit research institution.\u003c/p\u003e","\u003cp\u003eRepresented Jersey City Medical Center in its sale to Robert Wood Johnson/Barnabas Health System.\u003c/p\u003e","\u003cp\u003eRepresented Kayne Anderson Capital Advisors in connection with the New Jersey Department of Health for the change of ownership of an assisted living residence in New Jersey as a liaison between the client and the regulators.\u003c/p\u003e","\u003cp\u003eRepresented Kelsey-Seybold Medical Group in its sale to TPG Capital of a minority interest in its management services company.\u003c/p\u003e","\u003cp\u003eRepresented Kode Health, a tech-enabled medical coding company, in its $22.5 million Series B financing led by Noro-Moseley Partners with participation by FCA Venture Partners and Epsilon Healthcare Investors.\u003c/p\u003e","\u003cp\u003eRepresented Lehigh Valley Health Network in its merger with Jefferson Health creating a $14.0 billion integrated health delivery system in Eastern Pennsylvania.\u003c/p\u003e","\u003cp\u003eRepresented Medical Home Network in connection with counseling on a myriad of U.S. laws, state and federal Stark and anti-kickback laws, regulating healthcare payment and delivery systems, and best practices for distributing shared savings.\u003c/p\u003e","\u003cp\u003eRepresented Medical Home Network in the investment by Oak HC/FT.\u003c/p\u003e","\u003cp\u003eRepresented MEP Health, a Maryland-based physician emergency medicine group, in its merger with U.S. Acute Care Solutions.\u003c/p\u003e","\u003cp\u003eRepresented Mount Sinai Health System in its joint ventures with The Children's Hospital of Philadelphia (CHOP) and National Jewish Health.\u003c/p\u003e","\u003cp\u003eRepresented North Haven Credit Partners in connection with an investment and loan to Code 3, free standing emergency room centers in Texas and Nevada.\u003c/p\u003e","\u003cp\u003eRepresented Northern Westchester Hospital in its strategic health system affiliation with Northwell Health.\u003c/p\u003e","\u003cp\u003eRepresented Richmond University Medical Center in its acquisition of St. Vincent\u0026rsquo;s Staten Island Hospital, and sale of its interest in The Heart Institute to Staten Island University Hospital.\u003c/p\u003e","\u003cp\u003eRepresented Sentinel Capital Partners in their investment in MB2 Dental Solutions, a dental service organization with 85 affiliated practices.\u003c/p\u003e","\u003cp\u003eRepresented Sephardic Nursing and Rehabilitation Center in its sale to Allure, Inc. Solera Capital in the sale of its portfolio company The Little Clinic to the retailer Kroger, Inc.\u003c/p\u003e","\u003cp\u003eRepresented South Nassau Communities Hospital in its acquisition of Long Beach Medical Center.\u003c/p\u003e","\u003cp\u003eRepresented St. Luke\u0026rsquo;s-Roosevelt Hospital Center, Inc. in the spin-off of its outpatient primary care clinics to an affiliate of William F. Ryan Community Health Center, Inc.\u003c/p\u003e","\u003cp\u003eRepresented Teladoc, Inc., in connection with state licensing and regulatory compliance matters.\u003c/p\u003e","\u003cp\u003eRepresented Town Hall Ventures in its co-investment in VillageMD.\u003c/p\u003e","\u003cp\u003eRepresented Virginia Eye Consultants in its sale to CEI Vision Partners.\u003c/p\u003e","\u003cp\u003eRepresented WellBox, Inc. in its establishment of a Medicare chronic care management (CCM).\u003c/p\u003e"],"recognitions":[{"title":"Recognized for leading major transactions, including a $14 billion merger between Lehigh Valley Health Network and Jefferson Health","detail":"Law360 Healthcare MVP, 2024 "},{"title":"Ranked Band 1 for 19 consecutive years for excellence in healthcare transactional and regulatory law","detail":"Chambers USA: New York: Healthcare - 2023–2024 "},{"title":"Top Ranked Lawyer, Healthcare","detail":"Chambers USA, New York (2006-2022)"},{"title":"\"He is extremely knowledgeable and thoughtful...leaves no stone unturned...He is top of his field in healthcare law.\" ","detail":"Chambers USA (2022)"},{"title":"The Best Lawyers in America: Health Care Law","detail":"29th Edition, 2022"},{"title":"Chambers USA: Nationwide: Healthcare: Transactional","detail":"2012-2020"},{"title":"The Legal 500 United States: Healthcare \u0026 Life Sciences: Healthcare","detail":"2011"},{"title":"The Legal 500 United States: Healthcare: Service Providers","detail":"2013-2014, 2016-2020"},{"title":"Best Lawyers in America","detail":"1991-2021, 2025"},{"title":"New York Super Lawyers","detail":"2006-2020"},{"title":"Fellow","detail":"The New York Academy of Medicine"},{"title":"“Outstanding Healthcare Transaction Lawyer,” ","detail":"Nightingale’s Healthcare News"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":8531},{"id":8531},{"id":8531}]},"capability_group_id":2},"created_at":"2026-03-02T21:59:45.000Z","updated_at":"2026-03-02T21:59:45.000Z","searchable_text":"Zall{{ FIELD }}{:title=\u0026gt;\"Recognized for leading major transactions, including a $14 billion merger between Lehigh Valley Health Network and Jefferson Health\", :detail=\u0026gt;\"Law360 Healthcare MVP, 2024 \"}{{ FIELD }}{:title=\u0026gt;\"Ranked Band 1 for 19 consecutive years for excellence in healthcare transactional and regulatory law\", :detail=\u0026gt;\"Chambers USA: New York: Healthcare - 2023–2024 \"}{{ FIELD }}{:title=\u0026gt;\"Top Ranked Lawyer, Healthcare\", :detail=\u0026gt;\"Chambers USA, New York (2006-2022)\"}{{ FIELD }}{:title=\u0026gt;\"\\\"He is extremely knowledgeable and thoughtful...leaves no stone unturned...He is top of his field in healthcare law.\\\" \", :detail=\u0026gt;\"Chambers USA (2022)\"}{{ FIELD }}{:title=\u0026gt;\"The Best Lawyers in America: Health Care Law\", :detail=\u0026gt;\"29th Edition, 2022\"}{{ FIELD }}{:title=\u0026gt;\"Chambers USA: Nationwide: Healthcare: Transactional\", :detail=\u0026gt;\"2012-2020\"}{{ FIELD }}{:title=\u0026gt;\"The Legal 500 United States: Healthcare \u0026amp; Life Sciences: Healthcare\", :detail=\u0026gt;\"2011\"}{{ FIELD }}{:title=\u0026gt;\"The Legal 500 United States: Healthcare: Service Providers\", :detail=\u0026gt;\"2013-2014, 2016-2020\"}{{ FIELD }}{:title=\u0026gt;\"Best Lawyers in America\", :detail=\u0026gt;\"1991-2021, 2025\"}{{ FIELD }}{:title=\u0026gt;\"New York Super Lawyers\", :detail=\u0026gt;\"2006-2020\"}{{ FIELD }}{:title=\u0026gt;\"Fellow\", :detail=\u0026gt;\"The New York Academy of Medicine\"}{{ FIELD }}{:title=\u0026gt;\"“Outstanding Healthcare Transaction Lawyer,” \", :detail=\u0026gt;\"Nightingale’s Healthcare News\"}{{ FIELD }}Represented Accuity Delivery Systems in its sale to an affiliate of private equity firm, Frazier Healthcare Partners.{{ FIELD }}Represented Apnicure, a healthcare technology and medical device company, in connection with regulatory compliance state telemedicine laws and corporate structuring.{{ FIELD }}Represented Archimedes Health Investors and its portfolio company, National Partners in Health, in connection with the acquisition of Waxahachie Anaesthesia Consultants, National Medical Billing Management, Anaesthesia Resources, and TAMI and their related physician billing and practice management companies.{{ FIELD }}Represented Ares Management LLC, as special healthcare counsel in its acquisitions of both OB Hospitalist Group and Unified Physician Management.{{ FIELD }}Represented Ascension Health and it’s Our Lady of Lourdes Memorial Hospital in Binghamton, New York in its sale to The Guthrie Clinic.{{ FIELD }}Represented Bain Capital Ventures in its investment in Strategic Pharmaceutical Solutions, d/b/a Vetsource, an institutional pharmacy that dispenses prescription products to veterinarians and animal hospitals.{{ FIELD }}Represented The Brooklyn Hospital Center in the establishment of ModernMD, an urgent care joint venture with Blue Wolf Capital.{{ FIELD }}Represented Cambia Health in the establishment of a joint venture platform for Cambia (Regence Blue Cross) and Blue Cross/Blue Shield of North Carolina.{{ FIELD }}Represented Cincinnati Eye Institute (CEI) in the launch of CEI Vision Partners, a new management services organization formed with an investment from Revelstoke Capital Partners.{{ FIELD }}Represented Concerto Healthcare in the sale of its affiliated health plan in Michigan to Centene, a publicly traded HMO.{{ FIELD }}Represented Crystal Run Healthcare in the structuring of an ambulatory surgery joint venture with Orange Regional Medical Center.{{ FIELD }}Represented Data Driven Delivery Systems, LLC in its sale to Blue Cross Blue Shield of Michigan.{{ FIELD }}Represented Diana Health, a women’s health services company, in its $34.0 million Series B funding round led by Norwest Venture Partners with participation by .406 Ventures, LRV Health, and AlleyCorp.{{ FIELD }}Represented Eleanor Health, an outpatient addiction treatment provider, in its $50.0 million Series C financing, and $30.0 million Series D financing, led by General Catalyst with participation by Town Hall Ventures, Echo Health Ventures, Northpond Ventures, Rethink Impact and Emerson Collective.{{ FIELD }}Represented Healthcare Payment Specialists in their sale to acquirer, Nautic Partners Health Connect in establishing a joint venture between Newport Heath Solutions and Northwell Health to commercialize NHS’ population health management software.{{ FIELD }}Represented Helena Special Investments as corporate and regulatory counsel which led a $100.0 million Series A investment in Lykos Therapeutics, provider of MDMA-assisted therapy for PTSD. This transaction was challenging since Lykos is a subsidiary of Multidisciplinary Association for Psychedelic Studies (MAPS), a not-for-profit research institution.{{ FIELD }}Represented Jersey City Medical Center in its sale to Robert Wood Johnson/Barnabas Health System.{{ FIELD }}Represented Kayne Anderson Capital Advisors in connection with the New Jersey Department of Health for the change of ownership of an assisted living residence in New Jersey as a liaison between the client and the regulators.{{ FIELD }}Represented Kelsey-Seybold Medical Group in its sale to TPG Capital of a minority interest in its management services company.{{ FIELD }}Represented Kode Health, a tech-enabled medical coding company, in its $22.5 million Series B financing led by Noro-Moseley Partners with participation by FCA Venture Partners and Epsilon Healthcare Investors.{{ FIELD }}Represented Lehigh Valley Health Network in its merger with Jefferson Health creating a $14.0 billion integrated health delivery system in Eastern Pennsylvania.{{ FIELD }}Represented Medical Home Network in connection with counseling on a myriad of U.S. laws, state and federal Stark and anti-kickback laws, regulating healthcare payment and delivery systems, and best practices for distributing shared savings.{{ FIELD }}Represented Medical Home Network in the investment by Oak HC/FT.{{ FIELD }}Represented MEP Health, a Maryland-based physician emergency medicine group, in its merger with U.S. Acute Care Solutions.{{ FIELD }}Represented Mount Sinai Health System in its joint ventures with The Children's Hospital of Philadelphia (CHOP) and National Jewish Health.{{ FIELD }}Represented North Haven Credit Partners in connection with an investment and loan to Code 3, free standing emergency room centers in Texas and Nevada.{{ FIELD }}Represented Northern Westchester Hospital in its strategic health system affiliation with Northwell Health.{{ FIELD }}Represented Richmond University Medical Center in its acquisition of St. Vincent’s Staten Island Hospital, and sale of its interest in The Heart Institute to Staten Island University Hospital.{{ FIELD }}Represented Sentinel Capital Partners in their investment in MB2 Dental Solutions, a dental service organization with 85 affiliated practices.{{ FIELD }}Represented Sephardic Nursing and Rehabilitation Center in its sale to Allure, Inc. Solera Capital in the sale of its portfolio company The Little Clinic to the retailer Kroger, Inc.{{ FIELD }}Represented South Nassau Communities Hospital in its acquisition of Long Beach Medical Center.{{ FIELD }}Represented St. Luke’s-Roosevelt Hospital Center, Inc. in the spin-off of its outpatient primary care clinics to an affiliate of William F. Ryan Community Health Center, Inc.{{ FIELD }}Represented Teladoc, Inc., in connection with state licensing and regulatory compliance matters.{{ FIELD }}Represented Town Hall Ventures in its co-investment in VillageMD.{{ FIELD }}Represented Virginia Eye Consultants in its sale to CEI Vision Partners.{{ FIELD }}Represented WellBox, Inc. in its establishment of a Medicare chronic care management (CCM).{{ FIELD }}Rick Zall is a partner and chair of King \u0026amp; Spalding’s healthcare transactional and regulatory practice. He represents clients on both transactional and regulatory healthcare matters, including advising healthcare operating companies, private equity investors and lenders on M\u0026amp;A, joint ventures, financings and complex commercial transactions. He advises on state and federal healthcare regulatory compliance matters, including navigating fraud and abuse and corporate practice of medicine prohibitions, Medicare and Medicaid payment rules. Rick also counsels clients in the emerging digital health and health information technology sectors on compliance with data privacy and security laws, telemedicine licensure regulations and health benefit management.\nWith deep experience in the healthcare industry, Rick is known for practical and effective solutions to successfully structure, negotiate and close deals for his clients.\nRick advises clients on regulatory compliance matters including fraud and abuse, corporate practice of medicine, structuring physician incentive arrangements, digital health/telemedicine, HIPAA, Medicare/Medicaid reimbursement and value-based payments.\nPrior to joining King \u0026amp; Spalding, Rick was a partner and the chairman of the healthcare practice for an Am Law 100 firm. Richard Zall lawyer Partner Recognized for leading major transactions, including a $14 billion merger between Lehigh Valley Health Network and Jefferson Health Law360 Healthcare MVP, 2024  Ranked Band 1 for 19 consecutive years for excellence in healthcare transactional and regulatory law Chambers USA: New York: Healthcare - 2023–2024  Top Ranked Lawyer, Healthcare Chambers USA, New York (2006-2022) \"He is extremely knowledgeable and thoughtful...leaves no stone unturned...He is top of his field in healthcare law.\"  Chambers USA (2022) The Best Lawyers in America: Health Care Law 29th Edition, 2022 Chambers USA: Nationwide: Healthcare: Transactional 2012-2020 The Legal 500 United States: Healthcare \u0026amp; Life Sciences: Healthcare 2011 The Legal 500 United States: Healthcare: Service Providers 2013-2014, 2016-2020 Best Lawyers in America 1991-2021, 2025 New York Super Lawyers 2006-2020 Fellow The New York Academy of Medicine “Outstanding Healthcare Transaction Lawyer,”  Nightingale’s Healthcare News Brown University  New York University New York University School of Law New York Represented Accuity Delivery Systems in its sale to an affiliate of private equity firm, Frazier Healthcare Partners. Represented Apnicure, a healthcare technology and medical device company, in connection with regulatory compliance state telemedicine laws and corporate structuring. Represented Archimedes Health Investors and its portfolio company, National Partners in Health, in connection with the acquisition of Waxahachie Anaesthesia Consultants, National Medical Billing Management, Anaesthesia Resources, and TAMI and their related physician billing and practice management companies. Represented Ares Management LLC, as special healthcare counsel in its acquisitions of both OB Hospitalist Group and Unified Physician Management. Represented Ascension Health and it’s Our Lady of Lourdes Memorial Hospital in Binghamton, New York in its sale to The Guthrie Clinic. Represented Bain Capital Ventures in its investment in Strategic Pharmaceutical Solutions, d/b/a Vetsource, an institutional pharmacy that dispenses prescription products to veterinarians and animal hospitals. Represented The Brooklyn Hospital Center in the establishment of ModernMD, an urgent care joint venture with Blue Wolf Capital. Represented Cambia Health in the establishment of a joint venture platform for Cambia (Regence Blue Cross) and Blue Cross/Blue Shield of North Carolina. Represented Cincinnati Eye Institute (CEI) in the launch of CEI Vision Partners, a new management services organization formed with an investment from Revelstoke Capital Partners. Represented Concerto Healthcare in the sale of its affiliated health plan in Michigan to Centene, a publicly traded HMO. Represented Crystal Run Healthcare in the structuring of an ambulatory surgery joint venture with Orange Regional Medical Center. Represented Data Driven Delivery Systems, LLC in its sale to Blue Cross Blue Shield of Michigan. Represented Diana Health, a women’s health services company, in its $34.0 million Series B funding round led by Norwest Venture Partners with participation by .406 Ventures, LRV Health, and AlleyCorp. Represented Eleanor Health, an outpatient addiction treatment provider, in its $50.0 million Series C financing, and $30.0 million Series D financing, led by General Catalyst with participation by Town Hall Ventures, Echo Health Ventures, Northpond Ventures, Rethink Impact and Emerson Collective. Represented Healthcare Payment Specialists in their sale to acquirer, Nautic Partners Health Connect in establishing a joint venture between Newport Heath Solutions and Northwell Health to commercialize NHS’ population health management software. Represented Helena Special Investments as corporate and regulatory counsel which led a $100.0 million Series A investment in Lykos Therapeutics, provider of MDMA-assisted therapy for PTSD. This transaction was challenging since Lykos is a subsidiary of Multidisciplinary Association for Psychedelic Studies (MAPS), a not-for-profit research institution. Represented Jersey City Medical Center in its sale to Robert Wood Johnson/Barnabas Health System. Represented Kayne Anderson Capital Advisors in connection with the New Jersey Department of Health for the change of ownership of an assisted living residence in New Jersey as a liaison between the client and the regulators. Represented Kelsey-Seybold Medical Group in its sale to TPG Capital of a minority interest in its management services company. Represented Kode Health, a tech-enabled medical coding company, in its $22.5 million Series B financing led by Noro-Moseley Partners with participation by FCA Venture Partners and Epsilon Healthcare Investors. Represented Lehigh Valley Health Network in its merger with Jefferson Health creating a $14.0 billion integrated health delivery system in Eastern Pennsylvania. Represented Medical Home Network in connection with counseling on a myriad of U.S. laws, state and federal Stark and anti-kickback laws, regulating healthcare payment and delivery systems, and best practices for distributing shared savings. Represented Medical Home Network in the investment by Oak HC/FT. Represented MEP Health, a Maryland-based physician emergency medicine group, in its merger with U.S. Acute Care Solutions. Represented Mount Sinai Health System in its joint ventures with The Children's Hospital of Philadelphia (CHOP) and National Jewish Health. Represented North Haven Credit Partners in connection with an investment and loan to Code 3, free standing emergency room centers in Texas and Nevada. Represented Northern Westchester Hospital in its strategic health system affiliation with Northwell Health. Represented Richmond University Medical Center in its acquisition of St. Vincent’s Staten Island Hospital, and sale of its interest in The Heart Institute to Staten Island University Hospital. Represented Sentinel Capital Partners in their investment in MB2 Dental Solutions, a dental service organization with 85 affiliated practices. Represented Sephardic Nursing and Rehabilitation Center in its sale to Allure, Inc. Solera Capital in the sale of its portfolio company The Little Clinic to the retailer Kroger, Inc. Represented South Nassau Communities Hospital in its acquisition of Long Beach Medical Center. Represented St. Luke’s-Roosevelt Hospital Center, Inc. in the spin-off of its outpatient primary care clinics to an affiliate of William F. Ryan Community Health Center, Inc. Represented Teladoc, Inc., in connection with state licensing and regulatory compliance matters. Represented Town Hall Ventures in its co-investment in VillageMD. Represented Virginia Eye Consultants in its sale to CEI Vision Partners. Represented WellBox, Inc. in its establishment of a Medicare chronic care management (CCM).","searchable_name":"Richard Zall (Rick)","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":436369,"version":1,"owner_type":"Person","owner_id":2373,"payload":{"bio":"\u003cp\u003eDonald F. \u0026ldquo;Fritz\u0026rdquo; Zimmer, Jr. is a partner in our Trial and Global Disputes practice in San Francisco, where he served as Office Managing Partner for 10 years. Fritz defends companies in high profile pharmaceutical, medical device and environmental/toxic substances litigation, and also handles complex commercial disputes.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eFritz has served as national, regional, and trial counsel for a variety of pharmaceutical, chemical, medical device, and other product manufacturers in mass tort litigation. He has been named a \u0026ldquo;Lawyer of the Year\u0026rdquo; for Product Liability Litigation by Best Lawyers in America, a Northern California \u0026ldquo;Super Lawyer\u0026rdquo; for the past two decades, and has been rated highly by Legal 500 in Product Liability and Mass Tort Defense Litigation. \u0026ldquo;Who's Who Legal\u0026rdquo; (WWL) recently named Fritz as their top pick of 10 \u0026ldquo;Global Thought Leaders\u0026rdquo; for Products Liability Defense in North America, noting that clients and peers describe him as \u0026ldquo;a real trial lawyer who is very smart and thorough with knowledge of all the details of a case.\u0026rdquo; WWL also selected Fritz as one of the top 10 most highly regarded individuals in the U.S. for Product Liability Defense in 2015, noting that \u0026ldquo;peers and clients are effusive, claiming he has an exhaustive knowledge of the market and is peerless in court\u0026rdquo; and in 2014 observed that he is \u0026ldquo;counsel of choice for some of the largest pharmaceutical companies in the world, and a \u0026lsquo;leading light' in this field.\u0026rdquo;\u003c/p\u003e\n\u003cp\u003eFritz is a past member of the Board of Directors of the International Association of Defense Counsel (IADC), served as Director of the 2016 IADC Trial Academy at Stanford University Law School, and is an active member of the Defense Research Institute (DRI). He is a current board member and former Chairman of the Board of the American Diabetes Association\u0026rsquo;s Bay Area Chapter and is a frequent speaker and writer on topics related to litigation strategy.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003ePublications and Presentations\u003c/strong\u003e\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u0026ldquo;Medical Device Litigation \u0026ndash; What Really Matters\u0026rdquo; \u0026ndash; Medical Device Summit, Speaker, Washington, DC, October 2016.\u003c/li\u003e\n\u003cli\u003e\u0026ldquo;Pharma Innovation and Litigation Avoidance Strategies\u0026rdquo; \u0026ndash; Pharma U West, Speaker, San Francisco, CA, March 2015.\u003c/li\u003e\n\u003cli\u003e\u0026ldquo;Evaluating Evidence Used for Pharmacovigilance Signal Detection and Legal Causation Assessments\u0026rdquo;\u0026ndash;\u0026nbsp; \u0026ndash; ABA Tort Trial \u0026amp; Insurance Practice Section \u0026ndash; Life Science Legal Summit, Speaker, San Francisco, CA, March 2015.\u003c/li\u003e\n\u003cli\u003e\u0026ldquo;Product Liability Trends and Hot Topics\u0026rdquo; \u0026ndash; Medical Device Summit, Speaker, Palo Alto, CA, September 2014.\u003c/li\u003e\n\u003cli\u003e\u0026ldquo;Duty to Warn in a Digital Age\u0026rdquo; \u0026ndash; Pharma U West, Speaker, San Francisco, CA, March 2014.\u003c/li\u003e\n\u003cli\u003e\u0026ldquo;Showing Leadership in a High Profile Case\u0026rdquo; \u0026ndash; IADC International Corporate Counsel College, Speaker, Paris, France, November 2013.\u003c/li\u003e\n\u003cli\u003e\u0026ldquo;View From the Bench: Current Judicial Views on Pharmaceutical and Medical Device Litigation\u0026rdquo; -- ACI Drug and Medical Device Litigation Conference, Moderator, New York, December 2012\u003c/li\u003e\n\u003cli\u003e\u0026ldquo;Social Media \u0026ndash; A Double-Edged Sword in Managing Crises\u0026rdquo; \u0026ndash; IADC International Corporate Counsel College, Speaker, London, England, October 2012.\u003c/li\u003e\n\u003cli\u003e\u0026ldquo;Not Your Product?\u0026nbsp; I Still Say You are Liable: Plaintiffs\u0026rsquo; Efforts to Target Branded Manufacturers When Generic Medications Are Used\u0026rdquo; \u0026ndash; IADC Drug, Device and Biotechnology Committee Webinar, Speaker, August 2012.\u003c/li\u003e\n\u003cli\u003e\u0026ldquo;The Learned Intermediary Doctrine Under Attack\u0026rdquo; - DRI Drug \u0026amp; Medical Device Seminar, Speaker and author of paper, San Francisco, May 2010\u003c/li\u003e\n\u003cli\u003e\u0026ldquo;Hot Topics: Preemption, HIPAA, CAFA, State AG Investigations, and E-Discovery\u0026rdquo; - DRI Drug \u0026amp; Medical Device Seminar, Speaker and author of paper, San Francisco, May 2007\u003c/li\u003e\n\u003cli\u003e\u0026ldquo;Who Pays for Electronic Data Translation?\u0026nbsp; A Case Analysis of FRCP 34 and CCP 2031\u0026rdquo;-\u0026nbsp; IADC Drug, Device and Biotech Committee Newsletter, March 2005\u003c/li\u003e\n\u003cli\u003e\u0026ldquo;Lessons Learned in 10 years of Mass Torts\u0026rdquo; - Panel Presentation on MDL coordination procedures - IADC Annual Meeting; Maui, HI, July 2003\u003c/li\u003e\n\u003cli\u003e\u0026ldquo;Hot Topics: Federalism, Privacy, Preemption and Discovery\u0026rdquo;- DRI Drug \u0026amp; Medical Device Seminar, Speaker and author of paper, San Francisco, May 2002\u003c/li\u003e\n\u003cli\u003e\u0026ldquo;California Summary Judgment Standards in Toxic Tort Cases: Look Before You Leap\u0026rdquo; - IADC Toxic and Hazardous Substances Committee Newsletter, January 2001\u003c/li\u003e\n\u003cli\u003e\u0026ldquo;A Medicolegal Evaluation of Reversible Contraceptives\u0026rdquo; - Contemporary OB/GYN, Vol. 45, No. 5, May, 2000\u003c/li\u003e\n\u003cli\u003e\u0026ldquo;California\u0026rsquo;s Anti-SLAPP Statute and Pharmaceutical Free Speech\u0026rdquo; - IADC Drug, Device and Biotech Committee Newsletter, April, 2000\u003c/li\u003e\n\u003cli\u003e\u0026ldquo;How to Avoid, Control and Limit Depositions of Top Executives\u0026rdquo; - American Conference Institute (ACI) Drug \u0026amp; Medical Device Litigation Seminar - New York, December, 1997\u003c/li\u003e\n\u003cli\u003e\u0026ldquo;Dealing with the Co-Defendant Physician: A Manufacturer\u0026rsquo;s Perspective\u0026rdquo; - American Conference Institute (ACI) Drug \u0026amp; Medical Device Litigation Seminar, New York, December, 1996\u003c/li\u003e\n\u003c/ul\u003e","slug":"donald-zimmer","email":"fzimmer@kslaw.com","phone":null,"matters":["\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea manufacturer\u003c/strong\u003e in a three-month trial in Los Angeles relating to alleged PCB contamination of a natural gas pipeline.\u003c/p\u003e","\u003cp\u003eDefended \u003cstrong data-redactor-tag=\"strong\"\u003enumerous manufacturers of pharmaceutical products,\u003c/strong\u003e including vaccines, oral contraceptives, antidepressants, alendronate, phentermine, cisapride, rosiglitazone, rosuvastatin and saxagliptin.\u003c/p\u003e","\u003cp\u003eObtained a unanimous defense verdict as co-trial counsel in \u003cstrong data-redactor-tag=\"strong\"\u003ea wrongful death pharmaceutical product liability action\u003c/strong\u003e following an eight-week jury trial in Napa County, California.\u003c/p\u003e","\u003cp\u003eLead trial counsel in \u003cstrong data-redactor-tag=\"strong\"\u003ea living mesothelioma case\u003c/strong\u003e in New York Supreme Court where trial began, but was halted following successful removal of action.\u003c/p\u003e","\u003cp\u003eOne of trial counsel in two Los Angeles pharmaceutical cases involving \u003cstrong data-redactor-tag=\"strong\"\u003eType II diabetes medication,\u003c/strong\u003e which resolved during jury selection and pre-trial motions, respectively.\u003c/p\u003e","\u003cp\u003eDefended numerous \u003cstrong data-redactor-tag=\"strong\"\u003emanufacturers of medical devices,\u003c/strong\u003e including breast implants, IUD\u0026rsquo;s, intraocular lenses, tampons, blood glucose monitoring equipment, knee and hip prostheses and sutures.\u003c/p\u003e","\u003cp\u003eDefended \u003cstrong data-redactor-tag=\"strong\"\u003emanufacturers in several toxic substances matters\u003c/strong\u003e, including matters involving PCBs, asbestos-containing products, CERCLA claims, and chemical spills.\u003c/p\u003e","\u003cp\u003eDefended \u003cstrong data-redactor-tag=\"strong\"\u003ewrongful termination/employment disputes, laboratory testing/contract disputes,\u003c/strong\u003e other commercial litigation, and related matters for a variety of clients.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[{"id":168}]},"expertise":[{"id":74,"guid":"74.capabilities","index":0,"source":"capabilities"},{"id":3,"guid":"3.capabilities","index":1,"source":"capabilities"},{"id":5,"guid":"5.capabilities","index":2,"source":"capabilities"},{"id":15,"guid":"15.capabilities","index":3,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":4,"source":"capabilities"},{"id":761,"guid":"761.smart_tags","index":5,"source":"smartTags"},{"id":17,"guid":"17.capabilities","index":6,"source":"capabilities"},{"id":16,"guid":"16.capabilities","index":7,"source":"capabilities"},{"id":764,"guid":"764.smart_tags","index":8,"source":"smartTags"},{"id":970,"guid":"970.smart_tags","index":9,"source":"smartTags"},{"id":112,"guid":"112.capabilities","index":10,"source":"capabilities"}],"is_active":true,"last_name":"Zimmer","nick_name":"Fritz","clerkships":[],"first_name":"Donald","title_rank":9999,"updated_by":101,"law_schools":[],"middle_name":"F.","name_suffix":"Jr.","recognitions":[{"title":"One of the top 10 most highly regarded individuals in the United States for Product Liability Defense. Lauded for his “bespoke solutions” and “technical expertise.”","detail":"Who’s Who Legal, 2016"},{"title":"One of the top 10 most highly regarded individuals in the United States for Product Liability Defense. “Peers and clients are effusive, claiming he has an exhaustive knowledge of the market and is peerless in court.” ","detail":"Who’s Who Legal, 2015"},{"title":"“Counsel of choice for some of the largest pharmaceutical companies in the world, and a ‘leading light’ in this field.” ","detail":"Who’s Who Legal, 2014"},{"title":"Lawyer of the Year for Product Liability Litigation ","detail":"Best Lawyers in America, 2014"},{"title":"Northern California Super Lawyer ","detail":"Super Lawyers"}],"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eDonald F. \u0026ldquo;Fritz\u0026rdquo; Zimmer, Jr. is a partner in our Trial and Global Disputes practice in San Francisco, where he served as Office Managing Partner for 10 years. Fritz defends companies in high profile pharmaceutical, medical device and environmental/toxic substances litigation, and also handles complex commercial disputes.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eFritz has served as national, regional, and trial counsel for a variety of pharmaceutical, chemical, medical device, and other product manufacturers in mass tort litigation. He has been named a \u0026ldquo;Lawyer of the Year\u0026rdquo; for Product Liability Litigation by Best Lawyers in America, a Northern California \u0026ldquo;Super Lawyer\u0026rdquo; for the past two decades, and has been rated highly by Legal 500 in Product Liability and Mass Tort Defense Litigation. \u0026ldquo;Who's Who Legal\u0026rdquo; (WWL) recently named Fritz as their top pick of 10 \u0026ldquo;Global Thought Leaders\u0026rdquo; for Products Liability Defense in North America, noting that clients and peers describe him as \u0026ldquo;a real trial lawyer who is very smart and thorough with knowledge of all the details of a case.\u0026rdquo; WWL also selected Fritz as one of the top 10 most highly regarded individuals in the U.S. for Product Liability Defense in 2015, noting that \u0026ldquo;peers and clients are effusive, claiming he has an exhaustive knowledge of the market and is peerless in court\u0026rdquo; and in 2014 observed that he is \u0026ldquo;counsel of choice for some of the largest pharmaceutical companies in the world, and a \u0026lsquo;leading light' in this field.\u0026rdquo;\u003c/p\u003e\n\u003cp\u003eFritz is a past member of the Board of Directors of the International Association of Defense Counsel (IADC), served as Director of the 2016 IADC Trial Academy at Stanford University Law School, and is an active member of the Defense Research Institute (DRI). He is a current board member and former Chairman of the Board of the American Diabetes Association\u0026rsquo;s Bay Area Chapter and is a frequent speaker and writer on topics related to litigation strategy.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003ePublications and Presentations\u003c/strong\u003e\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u0026ldquo;Medical Device Litigation \u0026ndash; What Really Matters\u0026rdquo; \u0026ndash; Medical Device Summit, Speaker, Washington, DC, October 2016.\u003c/li\u003e\n\u003cli\u003e\u0026ldquo;Pharma Innovation and Litigation Avoidance Strategies\u0026rdquo; \u0026ndash; Pharma U West, Speaker, San Francisco, CA, March 2015.\u003c/li\u003e\n\u003cli\u003e\u0026ldquo;Evaluating Evidence Used for Pharmacovigilance Signal Detection and Legal Causation Assessments\u0026rdquo;\u0026ndash;\u0026nbsp; \u0026ndash; ABA Tort Trial \u0026amp; Insurance Practice Section \u0026ndash; Life Science Legal Summit, Speaker, San Francisco, CA, March 2015.\u003c/li\u003e\n\u003cli\u003e\u0026ldquo;Product Liability Trends and Hot Topics\u0026rdquo; \u0026ndash; Medical Device Summit, Speaker, Palo Alto, CA, September 2014.\u003c/li\u003e\n\u003cli\u003e\u0026ldquo;Duty to Warn in a Digital Age\u0026rdquo; \u0026ndash; Pharma U West, Speaker, San Francisco, CA, March 2014.\u003c/li\u003e\n\u003cli\u003e\u0026ldquo;Showing Leadership in a High Profile Case\u0026rdquo; \u0026ndash; IADC International Corporate Counsel College, Speaker, Paris, France, November 2013.\u003c/li\u003e\n\u003cli\u003e\u0026ldquo;View From the Bench: Current Judicial Views on Pharmaceutical and Medical Device Litigation\u0026rdquo; -- ACI Drug and Medical Device Litigation Conference, Moderator, New York, December 2012\u003c/li\u003e\n\u003cli\u003e\u0026ldquo;Social Media \u0026ndash; A Double-Edged Sword in Managing Crises\u0026rdquo; \u0026ndash; IADC International Corporate Counsel College, Speaker, London, England, October 2012.\u003c/li\u003e\n\u003cli\u003e\u0026ldquo;Not Your Product?\u0026nbsp; I Still Say You are Liable: Plaintiffs\u0026rsquo; Efforts to Target Branded Manufacturers When Generic Medications Are Used\u0026rdquo; \u0026ndash; IADC Drug, Device and Biotechnology Committee Webinar, Speaker, August 2012.\u003c/li\u003e\n\u003cli\u003e\u0026ldquo;The Learned Intermediary Doctrine Under Attack\u0026rdquo; - DRI Drug \u0026amp; Medical Device Seminar, Speaker and author of paper, San Francisco, May 2010\u003c/li\u003e\n\u003cli\u003e\u0026ldquo;Hot Topics: Preemption, HIPAA, CAFA, State AG Investigations, and E-Discovery\u0026rdquo; - DRI Drug \u0026amp; Medical Device Seminar, Speaker and author of paper, San Francisco, May 2007\u003c/li\u003e\n\u003cli\u003e\u0026ldquo;Who Pays for Electronic Data Translation?\u0026nbsp; A Case Analysis of FRCP 34 and CCP 2031\u0026rdquo;-\u0026nbsp; IADC Drug, Device and Biotech Committee Newsletter, March 2005\u003c/li\u003e\n\u003cli\u003e\u0026ldquo;Lessons Learned in 10 years of Mass Torts\u0026rdquo; - Panel Presentation on MDL coordination procedures - IADC Annual Meeting; Maui, HI, July 2003\u003c/li\u003e\n\u003cli\u003e\u0026ldquo;Hot Topics: Federalism, Privacy, Preemption and Discovery\u0026rdquo;- DRI Drug \u0026amp; Medical Device Seminar, Speaker and author of paper, San Francisco, May 2002\u003c/li\u003e\n\u003cli\u003e\u0026ldquo;California Summary Judgment Standards in Toxic Tort Cases: Look Before You Leap\u0026rdquo; - IADC Toxic and Hazardous Substances Committee Newsletter, January 2001\u003c/li\u003e\n\u003cli\u003e\u0026ldquo;A Medicolegal Evaluation of Reversible Contraceptives\u0026rdquo; - Contemporary OB/GYN, Vol. 45, No. 5, May, 2000\u003c/li\u003e\n\u003cli\u003e\u0026ldquo;California\u0026rsquo;s Anti-SLAPP Statute and Pharmaceutical Free Speech\u0026rdquo; - IADC Drug, Device and Biotech Committee Newsletter, April, 2000\u003c/li\u003e\n\u003cli\u003e\u0026ldquo;How to Avoid, Control and Limit Depositions of Top Executives\u0026rdquo; - American Conference Institute (ACI) Drug \u0026amp; Medical Device Litigation Seminar - New York, December, 1997\u003c/li\u003e\n\u003cli\u003e\u0026ldquo;Dealing with the Co-Defendant Physician: A Manufacturer\u0026rsquo;s Perspective\u0026rdquo; - American Conference Institute (ACI) Drug \u0026amp; Medical Device Litigation Seminar, New York, December, 1996\u003c/li\u003e\n\u003c/ul\u003e","matters":["\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea manufacturer\u003c/strong\u003e in a three-month trial in Los Angeles relating to alleged PCB contamination of a natural gas pipeline.\u003c/p\u003e","\u003cp\u003eDefended \u003cstrong data-redactor-tag=\"strong\"\u003enumerous manufacturers of pharmaceutical products,\u003c/strong\u003e including vaccines, oral contraceptives, antidepressants, alendronate, phentermine, cisapride, rosiglitazone, rosuvastatin and saxagliptin.\u003c/p\u003e","\u003cp\u003eObtained a unanimous defense verdict as co-trial counsel in \u003cstrong data-redactor-tag=\"strong\"\u003ea wrongful death pharmaceutical product liability action\u003c/strong\u003e following an eight-week jury trial in Napa County, California.\u003c/p\u003e","\u003cp\u003eLead trial counsel in \u003cstrong data-redactor-tag=\"strong\"\u003ea living mesothelioma case\u003c/strong\u003e in New York Supreme Court where trial began, but was halted following successful removal of action.\u003c/p\u003e","\u003cp\u003eOne of trial counsel in two Los Angeles pharmaceutical cases involving \u003cstrong data-redactor-tag=\"strong\"\u003eType II diabetes medication,\u003c/strong\u003e which resolved during jury selection and pre-trial motions, respectively.\u003c/p\u003e","\u003cp\u003eDefended numerous \u003cstrong data-redactor-tag=\"strong\"\u003emanufacturers of medical devices,\u003c/strong\u003e including breast implants, IUD\u0026rsquo;s, intraocular lenses, tampons, blood glucose monitoring equipment, knee and hip prostheses and sutures.\u003c/p\u003e","\u003cp\u003eDefended \u003cstrong data-redactor-tag=\"strong\"\u003emanufacturers in several toxic substances matters\u003c/strong\u003e, including matters involving PCBs, asbestos-containing products, CERCLA claims, and chemical spills.\u003c/p\u003e","\u003cp\u003eDefended \u003cstrong data-redactor-tag=\"strong\"\u003ewrongful termination/employment disputes, laboratory testing/contract disputes,\u003c/strong\u003e other commercial litigation, and related matters for a variety of clients.\u003c/p\u003e"],"recognitions":[{"title":"One of the top 10 most highly regarded individuals in the United States for Product Liability Defense. Lauded for his “bespoke solutions” and “technical expertise.”","detail":"Who’s Who Legal, 2016"},{"title":"One of the top 10 most highly regarded individuals in the United States for Product Liability Defense. “Peers and clients are effusive, claiming he has an exhaustive knowledge of the market and is peerless in court.” ","detail":"Who’s Who Legal, 2015"},{"title":"“Counsel of choice for some of the largest pharmaceutical companies in the world, and a ‘leading light’ in this field.” ","detail":"Who’s Who Legal, 2014"},{"title":"Lawyer of the Year for Product Liability Litigation ","detail":"Best Lawyers in America, 2014"},{"title":"Northern California Super Lawyer ","detail":"Super Lawyers"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":6060}]},"capability_group_id":3},"created_at":"2025-09-02T04:50:51.000Z","updated_at":"2025-09-02T04:50:51.000Z","searchable_text":"Zimmer{{ FIELD }}{:title=\u0026gt;\"One of the top 10 most highly regarded individuals in the United States for Product Liability Defense. Lauded for his “bespoke solutions” and “technical expertise.”\", :detail=\u0026gt;\"Who’s Who Legal, 2016\"}{{ FIELD }}{:title=\u0026gt;\"One of the top 10 most highly regarded individuals in the United States for Product Liability Defense. “Peers and clients are effusive, claiming he has an exhaustive knowledge of the market and is peerless in court.” \", :detail=\u0026gt;\"Who’s Who Legal, 2015\"}{{ FIELD }}{:title=\u0026gt;\"“Counsel of choice for some of the largest pharmaceutical companies in the world, and a ‘leading light’ in this field.” \", :detail=\u0026gt;\"Who’s Who Legal, 2014\"}{{ FIELD }}{:title=\u0026gt;\"Lawyer of the Year for Product Liability Litigation \", :detail=\u0026gt;\"Best Lawyers in America, 2014\"}{{ FIELD }}{:title=\u0026gt;\"Northern California Super Lawyer \", :detail=\u0026gt;\"Super Lawyers\"}{{ FIELD }}Represented a manufacturer in a three-month trial in Los Angeles relating to alleged PCB contamination of a natural gas pipeline.{{ FIELD }}Defended numerous manufacturers of pharmaceutical products, including vaccines, oral contraceptives, antidepressants, alendronate, phentermine, cisapride, rosiglitazone, rosuvastatin and saxagliptin.{{ FIELD }}Obtained a unanimous defense verdict as co-trial counsel in a wrongful death pharmaceutical product liability action following an eight-week jury trial in Napa County, California.{{ FIELD }}Lead trial counsel in a living mesothelioma case in New York Supreme Court where trial began, but was halted following successful removal of action.{{ FIELD }}One of trial counsel in two Los Angeles pharmaceutical cases involving Type II diabetes medication, which resolved during jury selection and pre-trial motions, respectively.{{ FIELD }}Defended numerous manufacturers of medical devices, including breast implants, IUD’s, intraocular lenses, tampons, blood glucose monitoring equipment, knee and hip prostheses and sutures.{{ FIELD }}Defended manufacturers in several toxic substances matters, including matters involving PCBs, asbestos-containing products, CERCLA claims, and chemical spills.{{ FIELD }}Defended wrongful termination/employment disputes, laboratory testing/contract disputes, other commercial litigation, and related matters for a variety of clients.{{ FIELD }}Donald F. “Fritz” Zimmer, Jr. is a partner in our Trial and Global Disputes practice in San Francisco, where he served as Office Managing Partner for 10 years. Fritz defends companies in high profile pharmaceutical, medical device and environmental/toxic substances litigation, and also handles complex commercial disputes.\nFritz has served as national, regional, and trial counsel for a variety of pharmaceutical, chemical, medical device, and other product manufacturers in mass tort litigation. He has been named a “Lawyer of the Year” for Product Liability Litigation by Best Lawyers in America, a Northern California “Super Lawyer” for the past two decades, and has been rated highly by Legal 500 in Product Liability and Mass Tort Defense Litigation. “Who's Who Legal” (WWL) recently named Fritz as their top pick of 10 “Global Thought Leaders” for Products Liability Defense in North America, noting that clients and peers describe him as “a real trial lawyer who is very smart and thorough with knowledge of all the details of a case.” WWL also selected Fritz as one of the top 10 most highly regarded individuals in the U.S. for Product Liability Defense in 2015, noting that “peers and clients are effusive, claiming he has an exhaustive knowledge of the market and is peerless in court” and in 2014 observed that he is “counsel of choice for some of the largest pharmaceutical companies in the world, and a ‘leading light' in this field.”\nFritz is a past member of the Board of Directors of the International Association of Defense Counsel (IADC), served as Director of the 2016 IADC Trial Academy at Stanford University Law School, and is an active member of the Defense Research Institute (DRI). He is a current board member and former Chairman of the Board of the American Diabetes Association’s Bay Area Chapter and is a frequent speaker and writer on topics related to litigation strategy.\nPublications and Presentations\n\n“Medical Device Litigation – What Really Matters” – Medical Device Summit, Speaker, Washington, DC, October 2016.\n“Pharma Innovation and Litigation Avoidance Strategies” – Pharma U West, Speaker, San Francisco, CA, March 2015.\n“Evaluating Evidence Used for Pharmacovigilance Signal Detection and Legal Causation Assessments”–  – ABA Tort Trial \u0026amp; Insurance Practice Section – Life Science Legal Summit, Speaker, San Francisco, CA, March 2015.\n“Product Liability Trends and Hot Topics” – Medical Device Summit, Speaker, Palo Alto, CA, September 2014.\n“Duty to Warn in a Digital Age” – Pharma U West, Speaker, San Francisco, CA, March 2014.\n“Showing Leadership in a High Profile Case” – IADC International Corporate Counsel College, Speaker, Paris, France, November 2013.\n“View From the Bench: Current Judicial Views on Pharmaceutical and Medical Device Litigation” -- ACI Drug and Medical Device Litigation Conference, Moderator, New York, December 2012\n“Social Media – A Double-Edged Sword in Managing Crises” – IADC International Corporate Counsel College, Speaker, London, England, October 2012.\n“Not Your Product?  I Still Say You are Liable: Plaintiffs’ Efforts to Target Branded Manufacturers When Generic Medications Are Used” – IADC Drug, Device and Biotechnology Committee Webinar, Speaker, August 2012.\n“The Learned Intermediary Doctrine Under Attack” - DRI Drug \u0026amp; Medical Device Seminar, Speaker and author of paper, San Francisco, May 2010\n“Hot Topics: Preemption, HIPAA, CAFA, State AG Investigations, and E-Discovery” - DRI Drug \u0026amp; Medical Device Seminar, Speaker and author of paper, San Francisco, May 2007\n“Who Pays for Electronic Data Translation?  A Case Analysis of FRCP 34 and CCP 2031”-  IADC Drug, Device and Biotech Committee Newsletter, March 2005\n“Lessons Learned in 10 years of Mass Torts” - Panel Presentation on MDL coordination procedures - IADC Annual Meeting; Maui, HI, July 2003\n“Hot Topics: Federalism, Privacy, Preemption and Discovery”- DRI Drug \u0026amp; Medical Device Seminar, Speaker and author of paper, San Francisco, May 2002\n“California Summary Judgment Standards in Toxic Tort Cases: Look Before You Leap” - IADC Toxic and Hazardous Substances Committee Newsletter, January 2001\n“A Medicolegal Evaluation of Reversible Contraceptives” - Contemporary OB/GYN, Vol. 45, No. 5, May, 2000\n“California’s Anti-SLAPP Statute and Pharmaceutical Free Speech” - IADC Drug, Device and Biotech Committee Newsletter, April, 2000\n“How to Avoid, Control and Limit Depositions of Top Executives” - American Conference Institute (ACI) Drug \u0026amp; Medical Device Litigation Seminar - New York, December, 1997\n“Dealing with the Co-Defendant Physician: A Manufacturer’s Perspective” - American Conference Institute (ACI) Drug \u0026amp; Medical Device Litigation Seminar, New York, December, 1996\n Donald F Zimmer Partner One of the top 10 most highly regarded individuals in the United States for Product Liability Defense. Lauded for his “bespoke solutions” and “technical expertise.” Who’s Who Legal, 2016 One of the top 10 most highly regarded individuals in the United States for Product Liability Defense. “Peers and clients are effusive, claiming he has an exhaustive knowledge of the market and is peerless in court.”  Who’s Who Legal, 2015 “Counsel of choice for some of the largest pharmaceutical companies in the world, and a ‘leading light’ in this field.”  Who’s Who Legal, 2014 Lawyer of the Year for Product Liability Litigation  Best Lawyers in America, 2014 Northern California Super Lawyer  Super Lawyers University of California-Riverside  Georgetown University Georgetown University Law Center U.S. District Court U.S. Court of Appeals for the Ninth Circuit U.S. District Court for the Central District of California U.S. District Court for the Eastern District of California U.S. District Court for the Northern District of California U.S. District Court for the Southern District of California California British Institute of International and Comparative Law (BIICL) Defense Research Institute (DRI) International Association of Defense Counsel (IADC) Member, IADC Board of Directors (2007-2010) and former Vice President of IADC Foundation Director, 2016 IADC Trial Academy and Faculty Member, 2002 IADC Trial Academy Member, DRI Drug \u0026amp; Medical Device Steering Committee Past Chairman, Golden Gate Chapter, American Diabetes Association (ADA) Represented a manufacturer in a three-month trial in Los Angeles relating to alleged PCB contamination of a natural gas pipeline. Defended numerous manufacturers of pharmaceutical products, including vaccines, oral contraceptives, antidepressants, alendronate, phentermine, cisapride, rosiglitazone, rosuvastatin and saxagliptin. Obtained a unanimous defense verdict as co-trial counsel in a wrongful death pharmaceutical product liability action following an eight-week jury trial in Napa County, California. Lead trial counsel in a living mesothelioma case in New York Supreme Court where trial began, but was halted following successful removal of action. One of trial counsel in two Los Angeles pharmaceutical cases involving Type II diabetes medication, which resolved during jury selection and pre-trial motions, respectively. Defended numerous manufacturers of medical devices, including breast implants, IUD’s, intraocular lenses, tampons, blood glucose monitoring equipment, knee and hip prostheses and sutures. Defended manufacturers in several toxic substances matters, including matters involving PCBs, asbestos-containing products, CERCLA claims, and chemical spills. Defended wrongful termination/employment disputes, laboratory testing/contract disputes, other commercial litigation, and related matters for a variety of clients.","searchable_name":"Donald F. Zimmer, Jr. (Fritz)","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":101,"capability_group_featured":null,"home_page_featured":null},{"id":446858,"version":1,"owner_type":"Person","owner_id":5447,"payload":{"bio":"\u003cp\u003eJulia Zousmer has more than fifteen years of experience defending pharmaceutical and consumer product manufacturers in complex product liability and mass tort litigation, including in federal multidistrict litigation (MDL) and state court coordinated proceedings.\u0026nbsp; She has managed dockets of hundreds and thousands of cases at all phases of the MDL lifecycle\u0026mdash;from pre-consolidation and MDL formation to negotiating and drafting they key foundational case management orders, developing and negotiating bellwether processes, trying bellwether cases, drafting motions dismissing hundreds of cases, and using case management tools to winnow meritless cases from the docket prior to global resolution.\u0026nbsp; Julia is a member of the Court-appointed Leadership Development Committee in the Zantac MDL in the Southern District of Florida and a key member of the team serving as national counsel for Boehringer Ingelheim in all Zantac litigation in state and federal court, which won an historic Daubert and Summary Judgment victory in the MDL disposing of approximately 50,000 claims.\u0026nbsp; She is playing a lead role in the Cook County consolidated proceeding, where she negotiated docketwide discovery procedures and contributed to motion practice that has reduced the 500+ plaintiff docket by more than 50% since creation and has played a role in all of the Zantac Cook County trials to date, each of which has ended in successful outcomes for Defendants.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eJulia has extensive trial experience, having achieved successful outcomes for clients on 17\u0026nbsp;trial teams in state and federal courts in some of the highest profile product liability MDLs of the past decade.\u003c/p\u003e\n\u003cp\u003eJulia is described in Chambers as\u0026nbsp;\"an excellent advocate for her clients,\"\u0026nbsp;\"a strong strategic thinker who is really talented at mass tort litigation,\" and \"a very skilled negotiator.\"\u0026nbsp; She was\u0026nbsp;recognized by Law360 as a Rising Star in Life Sciences and was selected for its Illinois Editorial Board, by Chicago Lawyer \u0026amp; Chicago Daily Law Bulletin as one of \u0026ldquo;40 Under Forty 2023 Illinois Attorneys to Watch,\u0026rdquo; by Legal 500 as a Key Lawyer in Product Liability, Mass Tort and Class Action Defense, by Best Lawyers as \"One to Watch\" in Product Liability and Mass Tort Litigation, and by Super Lawyers as a Rising Star for ten years in New York and Illinois.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eJulia is\u0026nbsp;a member of the International Association of Defense Counsel (IADC) and a member of the Board of Friends of Prentice, the fundraising arm of Northwestern's Prentice Women's Hospital that raises money for women's health in all realms.\u0026nbsp;\u003c/p\u003e","slug":"julia-zousmer","email":"jzousmer@kslaw.com","phone":null,"matters":["\u003cp\u003eCounsel for Boehringer Ingelheim Pharmaceuticals, Inc. in the\u0026nbsp;\u003cem\u003eIn Re Zantac\u003c/em\u003e\u0026nbsp;MDL with more than 150,000 claimants in the United States District Court for the Southern District of Florida, as well as in state court coordinated proceedings nationwide.\u003c/p\u003e","\u003cp\u003eRepresented Merck in two federal MDLs and two state court coordinated proceedings involving its osteoporosis medication Fosamax, including on six trial teams across four jurisdictions.\u003c/p\u003e","\u003cp\u003eRepresented Janssen at trial in the Philadelphia Court of Common Pleas in case involving allegations that its antipsychotic medication Risperdal causes gynecomastia. Successfully obtained non-suit for Janssen at the end of plaintiff\u0026rsquo;s case.\u003c/p\u003e","\u003cp\u003eRepresented J\u0026amp;J in a multi-plaintiff talcum powder trial in the City of St. Louis involving allegations that talcum powder causes ovarian cancer. Obtained mistrial for J\u0026amp;J on jurisdictional grounds when Supreme Court issued decision in\u0026nbsp;\u003cem\u003eBristol-Myers Squibb Co. v. Superior Court of California, San Francisco County, et al.\u003c/em\u003e, supporting the theory that jurisdiction in the City of St. Louis was improper.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":74,"guid":"74.capabilities","index":0,"source":"capabilities"},{"id":17,"guid":"17.capabilities","index":1,"source":"capabilities"},{"id":761,"guid":"761.smart_tags","index":2,"source":"smartTags"},{"id":1256,"guid":"1256.smart_tags","index":3,"source":"smartTags"},{"id":103,"guid":"103.capabilities","index":4,"source":"capabilities"},{"id":16,"guid":"16.capabilities","index":5,"source":"capabilities"},{"id":764,"guid":"764.smart_tags","index":6,"source":"smartTags"},{"id":112,"guid":"112.capabilities","index":7,"source":"capabilities"},{"id":3,"guid":"3.capabilities","index":8,"source":"capabilities"}],"is_active":true,"last_name":"Zousmer","nick_name":"Julia","clerkships":[{"name":"Intern, Stephen C. Robinson, U.S. District Court for the Southern District of New York","years_held":"2009 - 2009"}],"first_name":"Julia","title_rank":9999,"updated_by":202,"law_schools":[{"id":722,"meta":{"degree":"J.D.","honors":"","is_law_school":"1","graduation_date":"2010-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"","recognitions":[{"title":"Product Liability, Illinois","detail":"Chambers"},{"title":"Rising Star, Life Sciences","detail":"Law 360"},{"title":"40 Under Forty Illinois Attorneys to Watch","detail":"Chicago Lawyer \u0026 Chicago Daily Law Bulletin, 2023"},{"title":"Key Lawyer, Product Liability, Mass Tort and Class Action Defense - Pharmaceuticals and Medical Devices","detail":"Legal 500, 2022-2023"},{"title":"Illinois Editorial Board","detail":"Law 360"},{"title":"Ones to Watch - Product Liability Litigation - Defendants","detail":"Best Lawyers, 2024"},{"title":"Ones to Watch - Mass Tort Litigation/Class Actions - Defendants","detail":"Best Lawyers, 2024"},{"title":"Illinois Rising Star","detail":"Super Lawyers, 2018-2025"},{"title":"New York Rising Star","detail":"Super Lawyers, 2014-2016"}],"linked_in_url":"https://www.linkedin.com/in/juliazousmer/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eJulia Zousmer has more than fifteen years of experience defending pharmaceutical and consumer product manufacturers in complex product liability and mass tort litigation, including in federal multidistrict litigation (MDL) and state court coordinated proceedings.\u0026nbsp; She has managed dockets of hundreds and thousands of cases at all phases of the MDL lifecycle\u0026mdash;from pre-consolidation and MDL formation to negotiating and drafting they key foundational case management orders, developing and negotiating bellwether processes, trying bellwether cases, drafting motions dismissing hundreds of cases, and using case management tools to winnow meritless cases from the docket prior to global resolution.\u0026nbsp; Julia is a member of the Court-appointed Leadership Development Committee in the Zantac MDL in the Southern District of Florida and a key member of the team serving as national counsel for Boehringer Ingelheim in all Zantac litigation in state and federal court, which won an historic Daubert and Summary Judgment victory in the MDL disposing of approximately 50,000 claims.\u0026nbsp; She is playing a lead role in the Cook County consolidated proceeding, where she negotiated docketwide discovery procedures and contributed to motion practice that has reduced the 500+ plaintiff docket by more than 50% since creation and has played a role in all of the Zantac Cook County trials to date, each of which has ended in successful outcomes for Defendants.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eJulia has extensive trial experience, having achieved successful outcomes for clients on 17\u0026nbsp;trial teams in state and federal courts in some of the highest profile product liability MDLs of the past decade.\u003c/p\u003e\n\u003cp\u003eJulia is described in Chambers as\u0026nbsp;\"an excellent advocate for her clients,\"\u0026nbsp;\"a strong strategic thinker who is really talented at mass tort litigation,\" and \"a very skilled negotiator.\"\u0026nbsp; She was\u0026nbsp;recognized by Law360 as a Rising Star in Life Sciences and was selected for its Illinois Editorial Board, by Chicago Lawyer \u0026amp; Chicago Daily Law Bulletin as one of \u0026ldquo;40 Under Forty 2023 Illinois Attorneys to Watch,\u0026rdquo; by Legal 500 as a Key Lawyer in Product Liability, Mass Tort and Class Action Defense, by Best Lawyers as \"One to Watch\" in Product Liability and Mass Tort Litigation, and by Super Lawyers as a Rising Star for ten years in New York and Illinois.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eJulia is\u0026nbsp;a member of the International Association of Defense Counsel (IADC) and a member of the Board of Friends of Prentice, the fundraising arm of Northwestern's Prentice Women's Hospital that raises money for women's health in all realms.\u0026nbsp;\u003c/p\u003e","matters":["\u003cp\u003eCounsel for Boehringer Ingelheim Pharmaceuticals, Inc. in the\u0026nbsp;\u003cem\u003eIn Re Zantac\u003c/em\u003e\u0026nbsp;MDL with more than 150,000 claimants in the United States District Court for the Southern District of Florida, as well as in state court coordinated proceedings nationwide.\u003c/p\u003e","\u003cp\u003eRepresented Merck in two federal MDLs and two state court coordinated proceedings involving its osteoporosis medication Fosamax, including on six trial teams across four jurisdictions.\u003c/p\u003e","\u003cp\u003eRepresented Janssen at trial in the Philadelphia Court of Common Pleas in case involving allegations that its antipsychotic medication Risperdal causes gynecomastia. Successfully obtained non-suit for Janssen at the end of plaintiff\u0026rsquo;s case.\u003c/p\u003e","\u003cp\u003eRepresented J\u0026amp;J in a multi-plaintiff talcum powder trial in the City of St. Louis involving allegations that talcum powder causes ovarian cancer. Obtained mistrial for J\u0026amp;J on jurisdictional grounds when Supreme Court issued decision in\u0026nbsp;\u003cem\u003eBristol-Myers Squibb Co. v. Superior Court of California, San Francisco County, et al.\u003c/em\u003e, supporting the theory that jurisdiction in the City of St. Louis was improper.\u003c/p\u003e"],"recognitions":[{"title":"Product Liability, Illinois","detail":"Chambers"},{"title":"Rising Star, Life Sciences","detail":"Law 360"},{"title":"40 Under Forty Illinois Attorneys to Watch","detail":"Chicago Lawyer \u0026 Chicago Daily Law Bulletin, 2023"},{"title":"Key Lawyer, Product Liability, Mass Tort and Class Action Defense - Pharmaceuticals and Medical Devices","detail":"Legal 500, 2022-2023"},{"title":"Illinois Editorial Board","detail":"Law 360"},{"title":"Ones to Watch - Product Liability Litigation - Defendants","detail":"Best Lawyers, 2024"},{"title":"Ones to Watch - Mass Tort Litigation/Class Actions - Defendants","detail":"Best Lawyers, 2024"},{"title":"Illinois Rising Star","detail":"Super Lawyers, 2018-2025"},{"title":"New York Rising Star","detail":"Super Lawyers, 2014-2016"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":13424}]},"capability_group_id":3},"created_at":"2026-03-19T13:49:07.000Z","updated_at":"2026-03-19T13:49:07.000Z","searchable_text":"Zousmer{{ FIELD }}{:title=\u0026gt;\"Product Liability, Illinois\", :detail=\u0026gt;\"Chambers\"}{{ FIELD }}{:title=\u0026gt;\"Rising Star, Life Sciences\", :detail=\u0026gt;\"Law 360\"}{{ FIELD }}{:title=\u0026gt;\"40 Under Forty Illinois Attorneys to Watch\", :detail=\u0026gt;\"Chicago Lawyer \u0026amp; Chicago Daily Law Bulletin, 2023\"}{{ FIELD }}{:title=\u0026gt;\"Key Lawyer, Product Liability, Mass Tort and Class Action Defense - Pharmaceuticals and Medical Devices\", :detail=\u0026gt;\"Legal 500, 2022-2023\"}{{ FIELD }}{:title=\u0026gt;\"Illinois Editorial Board\", :detail=\u0026gt;\"Law 360\"}{{ FIELD }}{:title=\u0026gt;\"Ones to Watch - Product Liability Litigation - Defendants\", :detail=\u0026gt;\"Best Lawyers, 2024\"}{{ FIELD }}{:title=\u0026gt;\"Ones to Watch - Mass Tort Litigation/Class Actions - Defendants\", :detail=\u0026gt;\"Best Lawyers, 2024\"}{{ FIELD }}{:title=\u0026gt;\"Illinois Rising Star\", :detail=\u0026gt;\"Super Lawyers, 2018-2025\"}{{ FIELD }}{:title=\u0026gt;\"New York Rising Star\", :detail=\u0026gt;\"Super Lawyers, 2014-2016\"}{{ FIELD }}Counsel for Boehringer Ingelheim Pharmaceuticals, Inc. in the In Re Zantac MDL with more than 150,000 claimants in the United States District Court for the Southern District of Florida, as well as in state court coordinated proceedings nationwide.{{ FIELD }}Represented Merck in two federal MDLs and two state court coordinated proceedings involving its osteoporosis medication Fosamax, including on six trial teams across four jurisdictions.{{ FIELD }}Represented Janssen at trial in the Philadelphia Court of Common Pleas in case involving allegations that its antipsychotic medication Risperdal causes gynecomastia. Successfully obtained non-suit for Janssen at the end of plaintiff’s case.{{ FIELD }}Represented J\u0026amp;J in a multi-plaintiff talcum powder trial in the City of St. Louis involving allegations that talcum powder causes ovarian cancer. Obtained mistrial for J\u0026amp;J on jurisdictional grounds when Supreme Court issued decision in Bristol-Myers Squibb Co. v. Superior Court of California, San Francisco County, et al., supporting the theory that jurisdiction in the City of St. Louis was improper.{{ FIELD }}Julia Zousmer has more than fifteen years of experience defending pharmaceutical and consumer product manufacturers in complex product liability and mass tort litigation, including in federal multidistrict litigation (MDL) and state court coordinated proceedings.  She has managed dockets of hundreds and thousands of cases at all phases of the MDL lifecycle—from pre-consolidation and MDL formation to negotiating and drafting they key foundational case management orders, developing and negotiating bellwether processes, trying bellwether cases, drafting motions dismissing hundreds of cases, and using case management tools to winnow meritless cases from the docket prior to global resolution.  Julia is a member of the Court-appointed Leadership Development Committee in the Zantac MDL in the Southern District of Florida and a key member of the team serving as national counsel for Boehringer Ingelheim in all Zantac litigation in state and federal court, which won an historic Daubert and Summary Judgment victory in the MDL disposing of approximately 50,000 claims.  She is playing a lead role in the Cook County consolidated proceeding, where she negotiated docketwide discovery procedures and contributed to motion practice that has reduced the 500+ plaintiff docket by more than 50% since creation and has played a role in all of the Zantac Cook County trials to date, each of which has ended in successful outcomes for Defendants. \nJulia has extensive trial experience, having achieved successful outcomes for clients on 17 trial teams in state and federal courts in some of the highest profile product liability MDLs of the past decade.\nJulia is described in Chambers as \"an excellent advocate for her clients,\" \"a strong strategic thinker who is really talented at mass tort litigation,\" and \"a very skilled negotiator.\"  She was recognized by Law360 as a Rising Star in Life Sciences and was selected for its Illinois Editorial Board, by Chicago Lawyer \u0026amp; Chicago Daily Law Bulletin as one of “40 Under Forty 2023 Illinois Attorneys to Watch,” by Legal 500 as a Key Lawyer in Product Liability, Mass Tort and Class Action Defense, by Best Lawyers as \"One to Watch\" in Product Liability and Mass Tort Litigation, and by Super Lawyers as a Rising Star for ten years in New York and Illinois. \nJulia is a member of the International Association of Defense Counsel (IADC) and a member of the Board of Friends of Prentice, the fundraising arm of Northwestern's Prentice Women's Hospital that raises money for women's health in all realms.  Partner Product Liability, Illinois Chambers Rising Star, Life Sciences Law 360 40 Under Forty Illinois Attorneys to Watch Chicago Lawyer \u0026amp; Chicago Daily Law Bulletin, 2023 Key Lawyer, Product Liability, Mass Tort and Class Action Defense - Pharmaceuticals and Medical Devices Legal 500, 2022-2023 Illinois Editorial Board Law 360 Ones to Watch - Product Liability Litigation - Defendants Best Lawyers, 2024 Ones to Watch - Mass Tort Litigation/Class Actions - Defendants Best Lawyers, 2024 Illinois Rising Star Super Lawyers, 2018-2025 New York Rising Star Super Lawyers, 2014-2016 Cornell University Cornell Law School Fordham University Fordham University School of Law Illinois New York International Association of Defense Counsel Intern, Stephen C. Robinson, U.S. District Court for the Southern District of New York Counsel for Boehringer Ingelheim Pharmaceuticals, Inc. in the In Re Zantac MDL with more than 150,000 claimants in the United States District Court for the Southern District of Florida, as well as in state court coordinated proceedings nationwide. Represented Merck in two federal MDLs and two state court coordinated proceedings involving its osteoporosis medication Fosamax, including on six trial teams across four jurisdictions. Represented Janssen at trial in the Philadelphia Court of Common Pleas in case involving allegations that its antipsychotic medication Risperdal causes gynecomastia. Successfully obtained non-suit for Janssen at the end of plaintiff’s case. Represented J\u0026amp;J in a multi-plaintiff talcum powder trial in the City of St. Louis involving allegations that talcum powder causes ovarian cancer. Obtained mistrial for J\u0026amp;J on jurisdictional grounds when Supreme Court issued decision in Bristol-Myers Squibb Co. v. Superior Court of California, San Francisco County, et al., supporting the theory that jurisdiction in the City of St. Louis was improper.","searchable_name":"Julia Zousmer","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":445101,"version":1,"owner_type":"Person","owner_id":6076,"payload":{"bio":"\u003cp\u003eMark is an agile litigator\u0026nbsp;experienced with all stages of the case, from threat assessment and pre-filing diligence through verdict and post-trial motion practice.\u0026nbsp;He represents\u0026nbsp;plaintiffs and defendants in courts across the country in high-stakes intellectual property disputes\u0026nbsp;involving\u0026nbsp;complex technologies,\u0026nbsp;including security software, asset tracking systems, augmented reality military target acquisition systems, AI cameras and sensors, and oncolytic viruses.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eMark obtains decisive results for his clients through targeted discovery and motion practice. \u0026nbsp;In a recent billion-dollar technology licensing dispute, Mark and his team excluded four witnesses from offering expert opinions and prevailed on a cross-motion for summary judgment regarding whether an oncolytic viral drug used his client's patented invention. \u0026nbsp;The trial court granted summary judgment in Mark's client's favor and, from the bench, read into the record withering admissions from the opposing party's technical expert that Mark pried loose in deposition.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eAt trial, Mark and his team have secured complete defense verdicts against claims for hundreds of millions or billions of dollars in damages.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eMark's pro bono practice focuses on protecting the constitutional and civil rights of individuals and classes of disabled prisoners. Mark leverages his civil litigation skills to achieve significant systemic reforms and improve the conditions of confinement for this particularly vulnerable population.\u003c/p\u003e\n\u003cp\u003ePrior to joining King \u0026amp; Spalding, Mark served as a law clerk to the Honorable Philip A. Brimmer of the United States District Court for the District of Colorado.\u0026nbsp; During law school, Mark worked as a patent litigation intern at Google Inc.\u0026nbsp; He also served as a senior articles editor for the Berkeley Technology Law Journal.\u003c/p\u003e\n\u003cp\u003eBefore practicing law, Mark served as an infantry officer in the United States Army.\u0026nbsp; His military assignments include\u0026nbsp;leading a light infantry rifle platoon\u0026nbsp;during a year-long deployment to a fiercely contested region in eastern Afghanistan.\u0026nbsp; Mark's experience planning complex, multi-phase operations and then effectively communicating those plans to his platoon before leading them on combat missions\u0026nbsp;honed\u0026nbsp;the advocacy skills he deploys every day in his practice.\u003c/p\u003e","slug":"mark-zambarda","email":"mzambarda@kslaw.com","phone":null,"matters":["\u003cp\u003e\u003cstrong\u003ePlaintiff Representations\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eOpen Text S.A. v. Hyland\u0026nbsp;\u003c/em\u003e(C.D. Cal) \u0026ndash; counsel for Open Text in a series of patent infringement suits involving enterprise content management.\u003c/p\u003e","\u003cp\u003e\u003cem\u003eUnited Cannabis Corporation v. Pure Hemp Collective Inc.\u0026nbsp;\u003c/em\u003e(D. Colo.) \u0026ndash; counsel for United Cannabis Corporation in a patent infringement suit involving formulations of cannabis extracts.\u003c/p\u003e","\u003cp\u003e\u003cem\u003eOpen Text S.A. v. Alfresco Software Ltd. et al.\u0026nbsp;\u003c/em\u003e(W.D. Tex.) \u0026ndash; counsel for Open Text in a series of patent infringement suits involving enterprise content management.\u003c/p\u003e","\u003cp\u003e\u003cem\u003eScience Applications International Corporation v. United States\u0026nbsp;\u003c/em\u003e(COFC) \u0026ndash; counsel for Science Applications International Corporation in a patent infringement suit involving target acquisition systems and methods for dismounted troops.\u003c/p\u003e","\u003cp\u003e\u003cem\u003eMedline Industries v. C.R. Bard\u0026nbsp;\u003c/em\u003e(N.D. Ill.) \u0026ndash; counsel for Medline Industries in a series of patent infringement suits involving catheterization technology.\u003c/p\u003e","\u003cp\u003e\u003cem\u003eFacebook, Inc. v. BlackBerry Limited\u003c/em\u003e\u0026nbsp;(N.D. Cal.) \u0026ndash; counsel for Facebook, Inc. in a patent infringement suit involving location tracking software.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eDefendant Representations\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eOmnitracs, LLC et al. v. Motive Technologies, Inc.\u0026nbsp;(N.D. Cal.)\u0026nbsp;\u0026ndash;\u0026nbsp;\u003c/em\u003etrial counsel for Motive in a patent dispute involving vehicle electronic logging device and AI-camera technology. After a two week trial, Motive prevailed with a jury verdict of non-infringement of all ten claims.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eANI Pharmaceuticals, Inc. v. CG Oncology, Inc.\u003c/em\u003e\u0026nbsp;(Del. Sup. Ct.) \u0026ndash; trial counsel for CG Oncology in a patent assignment and trade secret dispute involving oncolytic virus technology. After a two week trial, CG Oncology prevailed with a jury verdict that it did not owe plaintiff damages under any of the asserted contract or unjust enrichment claims.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eFleet Connect Solutions LLC v. LKQ Corporation\u0026nbsp;(E.D. Tex.) \u0026ndash; \u003c/em\u003ecounsel for LKQ Corporation in a patent infringement suit involving fleet tracking and signal processing technologies.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eIdeal Innovations, Inc. et al. v. United States et al.\u0026nbsp;\u003c/em\u003e(COFC) \u0026ndash; counsel for General Dynamics Land Systems, Inc., Force Protection, Inc., and General Dynamics Land Systems \u0026ndash; Force Protection, Inc. in a patent infringement suit involving wheeled armored vehicles.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003ePanasonic Holdings Corp. v. Getac Tech. Corp.\u003c/em\u003e\u0026nbsp;(C.D. Cal.) \u0026ndash; counsel to defendant Getac Technology Corporation in design patent case related to ruggedized laptops.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eCanopy Growth Corporation v. GW Pharmaceuticals PLC\u003c/em\u003e\u0026nbsp;(W.D.Tex.) \u0026ndash; counsel for GW Pharmaceuticals PLC in a patent infringement suit involving methods for extracting cannabinoids.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eUniloc USA, Inc. et al. v. Piriform, Inc.\u0026nbsp;\u003c/em\u003e(E.D. Tex) \u0026ndash; counsel for Piriform in a patent infringement suit involving license management software.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eKaldren LLC v. Kik US, Inc.\u0026nbsp;\u003c/em\u003e(D. Del.) \u0026ndash; counsel for Kik US, Inc. in a series of patent infringement suits involving QR code software.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003ePTAB Actions\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eBlackBerry Corporation et al v. Facebook, Inc.\u003c/em\u003e\u0026nbsp;(PTAB-IPR2019-01593) \u0026ndash; counsel to patent owner Facebook, Inc. in\u0026nbsp;\u003cem\u003einter partes\u003c/em\u003e\u0026nbsp;review of patent relating to GPS management software.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eBlackBerry Corporation et al v. Facebook, Inc.\u003c/em\u003e\u0026nbsp;(PTAB-IPR2019-01596) \u0026ndash; counsel to patent owner Facebook, Inc. in\u0026nbsp;\u003cem\u003einter partes\u0026nbsp;\u003c/em\u003ereview of patent relating to computer system security.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eCrowdstrike, Inc. v. Open Text Inc.\u003c/em\u003e\u0026nbsp;(PTAB-IPR2023-00124) \u0026ndash; counsel to patent owner Open Text Inc. in\u0026nbsp;\u003cem\u003einter partes\u003c/em\u003e\u0026nbsp;review of patent relating to network security systems and methods of forensic malware analysis.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eCrowdstrike, Inc. v. Open Text Inc.\u003c/em\u003e\u0026nbsp;(PTAB-IPR2023-00126) \u0026ndash; counsel to patent owner Open Text Inc. in\u0026nbsp;\u003cem\u003einter partes\u003c/em\u003e\u0026nbsp;review of patent relating to network security systems and methods of forensic malware analysis.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eSophos Ltd., et al. v. Open Text Inc.\u003c/em\u003e\u0026nbsp;(PTAB-IPR2023-00491) \u0026ndash; counsel to patent owner Open Text Inc. in\u0026nbsp;\u003cem\u003einter partes\u003c/em\u003e\u0026nbsp;review of patent relating to methods and systems for mitigating malware.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eCrowdstrike, Inc. v. Open Text Inc.\u003c/em\u003e\u0026nbsp;(PTAB-IPR2023-00556) \u0026ndash; counsel to patent owner Open Text Inc. in\u0026nbsp;\u003cem\u003einter partes\u0026nbsp;\u003c/em\u003ereview of patent relating to systems and methods for identifying and classifying malware.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eTrend Micro, Inc. v. Open Text Inc.\u003c/em\u003e\u0026nbsp;(PTAB-IPR2023-00657) \u0026ndash; counsel to patent owner Open Text Inc. in\u0026nbsp;\u003cem\u003einter partes\u0026nbsp;\u003c/em\u003ereview of patent relating to network security systems and methods of forensic malware analysis.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eTrend Micro, Inc. v. Open Text Inc.\u003c/em\u003e\u0026nbsp;(PTAB-IPR2023-00677) \u0026ndash; counsel to patent owner Open Text Inc. in\u0026nbsp;\u003cem\u003einter partes\u0026nbsp;\u003c/em\u003ereview of patent relating to network security systems and methods of forensic malware analysis.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003ePro Bono Representations\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eChavez v. County of Santa Clara\u003c/em\u003e\u0026nbsp;(N.D. Cal) \u0026ndash; appointed class counsel to class of inmates challenging the Santa Clara County jail system's use of solitary confinement, disability discrimination, and provision of mental, medical, and dental care. Resolved through settlement under which Santa Clara County entered into a consent decree to address the identified issues, and is subject to future monitoring of compliance.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eMays v. County of Sacramento\u0026nbsp;\u003c/em\u003e(E.D. Cal) \u0026ndash; appointed class counsel to class of inmates challenging the Sacramento County jail system's overcrowding/understaffing, disability discrimination, provision of mental, medical, and dental care. Resolved through settlement under which Sacramento County entered into a consent decree to address the identified issues, and is subject to future monitoring of compliance.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eReed v. California Department of Corrections and Rehabilitation\u003c/em\u003e\u0026nbsp;(E.D. Cal.) \u0026ndash; appointed as pro bono counsel for a disabled prisoner pursuing Eighth Amendment, First Amendment, Americans with Disabilities Act, Rehabilitation Act, and related California state law claims. This matter is ongoing.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":74,"guid":"74.capabilities","index":0,"source":"capabilities"},{"id":13,"guid":"13.capabilities","index":1,"source":"capabilities"},{"id":1142,"guid":"1142.smart_tags","index":2,"source":"smartTags"},{"id":763,"guid":"763.smart_tags","index":3,"source":"smartTags"},{"id":761,"guid":"761.smart_tags","index":4,"source":"smartTags"},{"id":103,"guid":"103.capabilities","index":5,"source":"capabilities"},{"id":118,"guid":"118.capabilities","index":6,"source":"capabilities"}],"is_active":true,"last_name":"Zambarda","nick_name":"Mark","clerkships":[{"name":"Judicial Clerk, The Honorable Philip A. Brimmer, U.S. District Court for the District of Colorado","years_held":"2015 - 2016"}],"first_name":"Mark","title_rank":9999,"updated_by":202,"law_schools":[{"id":2159,"meta":{"degree":"J.D.","honors":"","is_law_school":"1","graduation_date":"2015-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"","recognitions":[{"title":"Ones to Watch, Intellectual Property Law","detail":"Best Lawyers 2024: Colorado"}],"linked_in_url":null,"seodescription":null,"primary_title_id":75,"translated_fields":{"en":{"bio":"\u003cp\u003eMark is an agile litigator\u0026nbsp;experienced with all stages of the case, from threat assessment and pre-filing diligence through verdict and post-trial motion practice.\u0026nbsp;He represents\u0026nbsp;plaintiffs and defendants in courts across the country in high-stakes intellectual property disputes\u0026nbsp;involving\u0026nbsp;complex technologies,\u0026nbsp;including security software, asset tracking systems, augmented reality military target acquisition systems, AI cameras and sensors, and oncolytic viruses.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eMark obtains decisive results for his clients through targeted discovery and motion practice. \u0026nbsp;In a recent billion-dollar technology licensing dispute, Mark and his team excluded four witnesses from offering expert opinions and prevailed on a cross-motion for summary judgment regarding whether an oncolytic viral drug used his client's patented invention. \u0026nbsp;The trial court granted summary judgment in Mark's client's favor and, from the bench, read into the record withering admissions from the opposing party's technical expert that Mark pried loose in deposition.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eAt trial, Mark and his team have secured complete defense verdicts against claims for hundreds of millions or billions of dollars in damages.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eMark's pro bono practice focuses on protecting the constitutional and civil rights of individuals and classes of disabled prisoners. Mark leverages his civil litigation skills to achieve significant systemic reforms and improve the conditions of confinement for this particularly vulnerable population.\u003c/p\u003e\n\u003cp\u003ePrior to joining King \u0026amp; Spalding, Mark served as a law clerk to the Honorable Philip A. Brimmer of the United States District Court for the District of Colorado.\u0026nbsp; During law school, Mark worked as a patent litigation intern at Google Inc.\u0026nbsp; He also served as a senior articles editor for the Berkeley Technology Law Journal.\u003c/p\u003e\n\u003cp\u003eBefore practicing law, Mark served as an infantry officer in the United States Army.\u0026nbsp; His military assignments include\u0026nbsp;leading a light infantry rifle platoon\u0026nbsp;during a year-long deployment to a fiercely contested region in eastern Afghanistan.\u0026nbsp; Mark's experience planning complex, multi-phase operations and then effectively communicating those plans to his platoon before leading them on combat missions\u0026nbsp;honed\u0026nbsp;the advocacy skills he deploys every day in his practice.\u003c/p\u003e","matters":["\u003cp\u003e\u003cstrong\u003ePlaintiff Representations\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eOpen Text S.A. v. Hyland\u0026nbsp;\u003c/em\u003e(C.D. Cal) \u0026ndash; counsel for Open Text in a series of patent infringement suits involving enterprise content management.\u003c/p\u003e","\u003cp\u003e\u003cem\u003eUnited Cannabis Corporation v. Pure Hemp Collective Inc.\u0026nbsp;\u003c/em\u003e(D. Colo.) \u0026ndash; counsel for United Cannabis Corporation in a patent infringement suit involving formulations of cannabis extracts.\u003c/p\u003e","\u003cp\u003e\u003cem\u003eOpen Text S.A. v. Alfresco Software Ltd. et al.\u0026nbsp;\u003c/em\u003e(W.D. Tex.) \u0026ndash; counsel for Open Text in a series of patent infringement suits involving enterprise content management.\u003c/p\u003e","\u003cp\u003e\u003cem\u003eScience Applications International Corporation v. United States\u0026nbsp;\u003c/em\u003e(COFC) \u0026ndash; counsel for Science Applications International Corporation in a patent infringement suit involving target acquisition systems and methods for dismounted troops.\u003c/p\u003e","\u003cp\u003e\u003cem\u003eMedline Industries v. C.R. Bard\u0026nbsp;\u003c/em\u003e(N.D. Ill.) \u0026ndash; counsel for Medline Industries in a series of patent infringement suits involving catheterization technology.\u003c/p\u003e","\u003cp\u003e\u003cem\u003eFacebook, Inc. v. BlackBerry Limited\u003c/em\u003e\u0026nbsp;(N.D. Cal.) \u0026ndash; counsel for Facebook, Inc. in a patent infringement suit involving location tracking software.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eDefendant Representations\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eOmnitracs, LLC et al. v. Motive Technologies, Inc.\u0026nbsp;(N.D. Cal.)\u0026nbsp;\u0026ndash;\u0026nbsp;\u003c/em\u003etrial counsel for Motive in a patent dispute involving vehicle electronic logging device and AI-camera technology. After a two week trial, Motive prevailed with a jury verdict of non-infringement of all ten claims.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eANI Pharmaceuticals, Inc. v. CG Oncology, Inc.\u003c/em\u003e\u0026nbsp;(Del. Sup. Ct.) \u0026ndash; trial counsel for CG Oncology in a patent assignment and trade secret dispute involving oncolytic virus technology. After a two week trial, CG Oncology prevailed with a jury verdict that it did not owe plaintiff damages under any of the asserted contract or unjust enrichment claims.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eFleet Connect Solutions LLC v. LKQ Corporation\u0026nbsp;(E.D. Tex.) \u0026ndash; \u003c/em\u003ecounsel for LKQ Corporation in a patent infringement suit involving fleet tracking and signal processing technologies.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eIdeal Innovations, Inc. et al. v. United States et al.\u0026nbsp;\u003c/em\u003e(COFC) \u0026ndash; counsel for General Dynamics Land Systems, Inc., Force Protection, Inc., and General Dynamics Land Systems \u0026ndash; Force Protection, Inc. in a patent infringement suit involving wheeled armored vehicles.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003ePanasonic Holdings Corp. v. Getac Tech. Corp.\u003c/em\u003e\u0026nbsp;(C.D. Cal.) \u0026ndash; counsel to defendant Getac Technology Corporation in design patent case related to ruggedized laptops.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eCanopy Growth Corporation v. GW Pharmaceuticals PLC\u003c/em\u003e\u0026nbsp;(W.D.Tex.) \u0026ndash; counsel for GW Pharmaceuticals PLC in a patent infringement suit involving methods for extracting cannabinoids.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eUniloc USA, Inc. et al. v. Piriform, Inc.\u0026nbsp;\u003c/em\u003e(E.D. Tex) \u0026ndash; counsel for Piriform in a patent infringement suit involving license management software.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eKaldren LLC v. Kik US, Inc.\u0026nbsp;\u003c/em\u003e(D. Del.) \u0026ndash; counsel for Kik US, Inc. in a series of patent infringement suits involving QR code software.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003ePTAB Actions\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eBlackBerry Corporation et al v. Facebook, Inc.\u003c/em\u003e\u0026nbsp;(PTAB-IPR2019-01593) \u0026ndash; counsel to patent owner Facebook, Inc. in\u0026nbsp;\u003cem\u003einter partes\u003c/em\u003e\u0026nbsp;review of patent relating to GPS management software.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eBlackBerry Corporation et al v. Facebook, Inc.\u003c/em\u003e\u0026nbsp;(PTAB-IPR2019-01596) \u0026ndash; counsel to patent owner Facebook, Inc. in\u0026nbsp;\u003cem\u003einter partes\u0026nbsp;\u003c/em\u003ereview of patent relating to computer system security.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eCrowdstrike, Inc. v. Open Text Inc.\u003c/em\u003e\u0026nbsp;(PTAB-IPR2023-00124) \u0026ndash; counsel to patent owner Open Text Inc. in\u0026nbsp;\u003cem\u003einter partes\u003c/em\u003e\u0026nbsp;review of patent relating to network security systems and methods of forensic malware analysis.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eCrowdstrike, Inc. v. Open Text Inc.\u003c/em\u003e\u0026nbsp;(PTAB-IPR2023-00126) \u0026ndash; counsel to patent owner Open Text Inc. in\u0026nbsp;\u003cem\u003einter partes\u003c/em\u003e\u0026nbsp;review of patent relating to network security systems and methods of forensic malware analysis.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eSophos Ltd., et al. v. Open Text Inc.\u003c/em\u003e\u0026nbsp;(PTAB-IPR2023-00491) \u0026ndash; counsel to patent owner Open Text Inc. in\u0026nbsp;\u003cem\u003einter partes\u003c/em\u003e\u0026nbsp;review of patent relating to methods and systems for mitigating malware.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eCrowdstrike, Inc. v. Open Text Inc.\u003c/em\u003e\u0026nbsp;(PTAB-IPR2023-00556) \u0026ndash; counsel to patent owner Open Text Inc. in\u0026nbsp;\u003cem\u003einter partes\u0026nbsp;\u003c/em\u003ereview of patent relating to systems and methods for identifying and classifying malware.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eTrend Micro, Inc. v. Open Text Inc.\u003c/em\u003e\u0026nbsp;(PTAB-IPR2023-00657) \u0026ndash; counsel to patent owner Open Text Inc. in\u0026nbsp;\u003cem\u003einter partes\u0026nbsp;\u003c/em\u003ereview of patent relating to network security systems and methods of forensic malware analysis.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eTrend Micro, Inc. v. Open Text Inc.\u003c/em\u003e\u0026nbsp;(PTAB-IPR2023-00677) \u0026ndash; counsel to patent owner Open Text Inc. in\u0026nbsp;\u003cem\u003einter partes\u0026nbsp;\u003c/em\u003ereview of patent relating to network security systems and methods of forensic malware analysis.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003ePro Bono Representations\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eChavez v. County of Santa Clara\u003c/em\u003e\u0026nbsp;(N.D. Cal) \u0026ndash; appointed class counsel to class of inmates challenging the Santa Clara County jail system's use of solitary confinement, disability discrimination, and provision of mental, medical, and dental care. Resolved through settlement under which Santa Clara County entered into a consent decree to address the identified issues, and is subject to future monitoring of compliance.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eMays v. County of Sacramento\u0026nbsp;\u003c/em\u003e(E.D. Cal) \u0026ndash; appointed class counsel to class of inmates challenging the Sacramento County jail system's overcrowding/understaffing, disability discrimination, provision of mental, medical, and dental care. Resolved through settlement under which Sacramento County entered into a consent decree to address the identified issues, and is subject to future monitoring of compliance.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eReed v. California Department of Corrections and Rehabilitation\u003c/em\u003e\u0026nbsp;(E.D. Cal.) \u0026ndash; appointed as pro bono counsel for a disabled prisoner pursuing Eighth Amendment, First Amendment, Americans with Disabilities Act, Rehabilitation Act, and related California state law claims. This matter is ongoing.\u003c/p\u003e"],"recognitions":[{"title":"Ones to Watch, Intellectual Property Law","detail":"Best Lawyers 2024: Colorado"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":9088}]},"capability_group_id":3},"created_at":"2026-01-16T21:39:50.000Z","updated_at":"2026-01-16T21:39:50.000Z","searchable_text":"Zambarda{{ FIELD }}{:title=\u0026gt;\"Ones to Watch, Intellectual Property Law\", :detail=\u0026gt;\"Best Lawyers 2024: Colorado\"}{{ FIELD }}Plaintiff Representations\nOpen Text S.A. v. Hyland (C.D. Cal) – counsel for Open Text in a series of patent infringement suits involving enterprise content management.{{ FIELD }}United Cannabis Corporation v. Pure Hemp Collective Inc. (D. Colo.) – counsel for United Cannabis Corporation in a patent infringement suit involving formulations of cannabis extracts.{{ FIELD }}Open Text S.A. v. Alfresco Software Ltd. et al. (W.D. Tex.) – counsel for Open Text in a series of patent infringement suits involving enterprise content management.{{ FIELD }}Science Applications International Corporation v. United States (COFC) – counsel for Science Applications International Corporation in a patent infringement suit involving target acquisition systems and methods for dismounted troops.{{ FIELD }}Medline Industries v. C.R. Bard (N.D. Ill.) – counsel for Medline Industries in a series of patent infringement suits involving catheterization technology.{{ FIELD }}Facebook, Inc. v. BlackBerry Limited (N.D. Cal.) – counsel for Facebook, Inc. in a patent infringement suit involving location tracking software.{{ FIELD }}Defendant Representations\nOmnitracs, LLC et al. v. Motive Technologies, Inc. (N.D. Cal.) – trial counsel for Motive in a patent dispute involving vehicle electronic logging device and AI-camera technology. After a two week trial, Motive prevailed with a jury verdict of non-infringement of all ten claims.\nANI Pharmaceuticals, Inc. v. CG Oncology, Inc. (Del. Sup. Ct.) – trial counsel for CG Oncology in a patent assignment and trade secret dispute involving oncolytic virus technology. After a two week trial, CG Oncology prevailed with a jury verdict that it did not owe plaintiff damages under any of the asserted contract or unjust enrichment claims.\nFleet Connect Solutions LLC v. LKQ Corporation (E.D. Tex.) – counsel for LKQ Corporation in a patent infringement suit involving fleet tracking and signal processing technologies.\nIdeal Innovations, Inc. et al. v. United States et al. (COFC) – counsel for General Dynamics Land Systems, Inc., Force Protection, Inc., and General Dynamics Land Systems – Force Protection, Inc. in a patent infringement suit involving wheeled armored vehicles.\nPanasonic Holdings Corp. v. Getac Tech. Corp. (C.D. Cal.) – counsel to defendant Getac Technology Corporation in design patent case related to ruggedized laptops.\nCanopy Growth Corporation v. GW Pharmaceuticals PLC (W.D.Tex.) – counsel for GW Pharmaceuticals PLC in a patent infringement suit involving methods for extracting cannabinoids.\nUniloc USA, Inc. et al. v. Piriform, Inc. (E.D. Tex) – counsel for Piriform in a patent infringement suit involving license management software.\nKaldren LLC v. Kik US, Inc. (D. Del.) – counsel for Kik US, Inc. in a series of patent infringement suits involving QR code software.{{ FIELD }}PTAB Actions\nBlackBerry Corporation et al v. Facebook, Inc. (PTAB-IPR2019-01593) – counsel to patent owner Facebook, Inc. in inter partes review of patent relating to GPS management software.\nBlackBerry Corporation et al v. Facebook, Inc. (PTAB-IPR2019-01596) – counsel to patent owner Facebook, Inc. in inter partes review of patent relating to computer system security.\nCrowdstrike, Inc. v. Open Text Inc. (PTAB-IPR2023-00124) – counsel to patent owner Open Text Inc. in inter partes review of patent relating to network security systems and methods of forensic malware analysis.\nCrowdstrike, Inc. v. Open Text Inc. (PTAB-IPR2023-00126) – counsel to patent owner Open Text Inc. in inter partes review of patent relating to network security systems and methods of forensic malware analysis.\nSophos Ltd., et al. v. Open Text Inc. (PTAB-IPR2023-00491) – counsel to patent owner Open Text Inc. in inter partes review of patent relating to methods and systems for mitigating malware.\nCrowdstrike, Inc. v. Open Text Inc. (PTAB-IPR2023-00556) – counsel to patent owner Open Text Inc. in inter partes review of patent relating to systems and methods for identifying and classifying malware.\nTrend Micro, Inc. v. Open Text Inc. (PTAB-IPR2023-00657) – counsel to patent owner Open Text Inc. in inter partes review of patent relating to network security systems and methods of forensic malware analysis.\nTrend Micro, Inc. v. Open Text Inc. (PTAB-IPR2023-00677) – counsel to patent owner Open Text Inc. in inter partes review of patent relating to network security systems and methods of forensic malware analysis.{{ FIELD }}Pro Bono Representations\nChavez v. County of Santa Clara (N.D. Cal) – appointed class counsel to class of inmates challenging the Santa Clara County jail system's use of solitary confinement, disability discrimination, and provision of mental, medical, and dental care. Resolved through settlement under which Santa Clara County entered into a consent decree to address the identified issues, and is subject to future monitoring of compliance.\nMays v. County of Sacramento (E.D. Cal) – appointed class counsel to class of inmates challenging the Sacramento County jail system's overcrowding/understaffing, disability discrimination, provision of mental, medical, and dental care. Resolved through settlement under which Sacramento County entered into a consent decree to address the identified issues, and is subject to future monitoring of compliance.\nReed v. California Department of Corrections and Rehabilitation (E.D. Cal.) – appointed as pro bono counsel for a disabled prisoner pursuing Eighth Amendment, First Amendment, Americans with Disabilities Act, Rehabilitation Act, and related California state law claims. This matter is ongoing.{{ FIELD }}Mark is an agile litigator experienced with all stages of the case, from threat assessment and pre-filing diligence through verdict and post-trial motion practice. He represents plaintiffs and defendants in courts across the country in high-stakes intellectual property disputes involving complex technologies, including security software, asset tracking systems, augmented reality military target acquisition systems, AI cameras and sensors, and oncolytic viruses. \nMark obtains decisive results for his clients through targeted discovery and motion practice.  In a recent billion-dollar technology licensing dispute, Mark and his team excluded four witnesses from offering expert opinions and prevailed on a cross-motion for summary judgment regarding whether an oncolytic viral drug used his client's patented invention.  The trial court granted summary judgment in Mark's client's favor and, from the bench, read into the record withering admissions from the opposing party's technical expert that Mark pried loose in deposition. \nAt trial, Mark and his team have secured complete defense verdicts against claims for hundreds of millions or billions of dollars in damages. \nMark's pro bono practice focuses on protecting the constitutional and civil rights of individuals and classes of disabled prisoners. Mark leverages his civil litigation skills to achieve significant systemic reforms and improve the conditions of confinement for this particularly vulnerable population.\nPrior to joining King \u0026amp; Spalding, Mark served as a law clerk to the Honorable Philip A. Brimmer of the United States District Court for the District of Colorado.  During law school, Mark worked as a patent litigation intern at Google Inc.  He also served as a senior articles editor for the Berkeley Technology Law Journal.\nBefore practicing law, Mark served as an infantry officer in the United States Army.  His military assignments include leading a light infantry rifle platoon during a year-long deployment to a fiercely contested region in eastern Afghanistan.  Mark's experience planning complex, multi-phase operations and then effectively communicating those plans to his platoon before leading them on combat missions honed the advocacy skills he deploys every day in his practice. Senior Associate Ones to Watch, Intellectual Property Law Best Lawyers 2024: Colorado United States Military Academy  University of California, Berkeley University of California, Berkeley, School of Law U.S. Court of Appeals for the Ninth Circuit U.S. Court of Federal Claims U.S. District Court for the Eastern District of Texas U.S. District Court for the Central District of California U.S. District Court for the Eastern District of California U.S. District Court for the Northern District of California U.S. District Court for the Southern District of California U.S. District Court for the District of Colorado California Colorado Judicial Clerk, The Honorable Philip A. Brimmer, U.S. District Court for the District of Colorado Plaintiff Representations\nOpen Text S.A. v. Hyland (C.D. Cal) – counsel for Open Text in a series of patent infringement suits involving enterprise content management. United Cannabis Corporation v. Pure Hemp Collective Inc. (D. Colo.) – counsel for United Cannabis Corporation in a patent infringement suit involving formulations of cannabis extracts. Open Text S.A. v. Alfresco Software Ltd. et al. (W.D. Tex.) – counsel for Open Text in a series of patent infringement suits involving enterprise content management. Science Applications International Corporation v. United States (COFC) – counsel for Science Applications International Corporation in a patent infringement suit involving target acquisition systems and methods for dismounted troops. Medline Industries v. C.R. Bard (N.D. Ill.) – counsel for Medline Industries in a series of patent infringement suits involving catheterization technology. Facebook, Inc. v. BlackBerry Limited (N.D. Cal.) – counsel for Facebook, Inc. in a patent infringement suit involving location tracking software. Defendant Representations\nOmnitracs, LLC et al. v. Motive Technologies, Inc. (N.D. Cal.) – trial counsel for Motive in a patent dispute involving vehicle electronic logging device and AI-camera technology. After a two week trial, Motive prevailed with a jury verdict of non-infringement of all ten claims.\nANI Pharmaceuticals, Inc. v. CG Oncology, Inc. (Del. Sup. Ct.) – trial counsel for CG Oncology in a patent assignment and trade secret dispute involving oncolytic virus technology. After a two week trial, CG Oncology prevailed with a jury verdict that it did not owe plaintiff damages under any of the asserted contract or unjust enrichment claims.\nFleet Connect Solutions LLC v. LKQ Corporation (E.D. Tex.) – counsel for LKQ Corporation in a patent infringement suit involving fleet tracking and signal processing technologies.\nIdeal Innovations, Inc. et al. v. United States et al. (COFC) – counsel for General Dynamics Land Systems, Inc., Force Protection, Inc., and General Dynamics Land Systems – Force Protection, Inc. in a patent infringement suit involving wheeled armored vehicles.\nPanasonic Holdings Corp. v. Getac Tech. Corp. (C.D. Cal.) – counsel to defendant Getac Technology Corporation in design patent case related to ruggedized laptops.\nCanopy Growth Corporation v. GW Pharmaceuticals PLC (W.D.Tex.) – counsel for GW Pharmaceuticals PLC in a patent infringement suit involving methods for extracting cannabinoids.\nUniloc USA, Inc. et al. v. Piriform, Inc. (E.D. Tex) – counsel for Piriform in a patent infringement suit involving license management software.\nKaldren LLC v. Kik US, Inc. (D. Del.) – counsel for Kik US, Inc. in a series of patent infringement suits involving QR code software. PTAB Actions\nBlackBerry Corporation et al v. Facebook, Inc. (PTAB-IPR2019-01593) – counsel to patent owner Facebook, Inc. in inter partes review of patent relating to GPS management software.\nBlackBerry Corporation et al v. Facebook, Inc. (PTAB-IPR2019-01596) – counsel to patent owner Facebook, Inc. in inter partes review of patent relating to computer system security.\nCrowdstrike, Inc. v. Open Text Inc. (PTAB-IPR2023-00124) – counsel to patent owner Open Text Inc. in inter partes review of patent relating to network security systems and methods of forensic malware analysis.\nCrowdstrike, Inc. v. Open Text Inc. (PTAB-IPR2023-00126) – counsel to patent owner Open Text Inc. in inter partes review of patent relating to network security systems and methods of forensic malware analysis.\nSophos Ltd., et al. v. Open Text Inc. (PTAB-IPR2023-00491) – counsel to patent owner Open Text Inc. in inter partes review of patent relating to methods and systems for mitigating malware.\nCrowdstrike, Inc. v. Open Text Inc. (PTAB-IPR2023-00556) – counsel to patent owner Open Text Inc. in inter partes review of patent relating to systems and methods for identifying and classifying malware.\nTrend Micro, Inc. v. Open Text Inc. (PTAB-IPR2023-00657) – counsel to patent owner Open Text Inc. in inter partes review of patent relating to network security systems and methods of forensic malware analysis.\nTrend Micro, Inc. v. Open Text Inc. (PTAB-IPR2023-00677) – counsel to patent owner Open Text Inc. in inter partes review of patent relating to network security systems and methods of forensic malware analysis. Pro Bono Representations\nChavez v. County of Santa Clara (N.D. Cal) – appointed class counsel to class of inmates challenging the Santa Clara County jail system's use of solitary confinement, disability discrimination, and provision of mental, medical, and dental care. Resolved through settlement under which Santa Clara County entered into a consent decree to address the identified issues, and is subject to future monitoring of compliance.\nMays v. County of Sacramento (E.D. Cal) – appointed class counsel to class of inmates challenging the Sacramento County jail system's overcrowding/understaffing, disability discrimination, provision of mental, medical, and dental care. Resolved through settlement under which Sacramento County entered into a consent decree to address the identified issues, and is subject to future monitoring of compliance.\nReed v. California Department of Corrections and Rehabilitation (E.D. Cal.) – appointed as pro bono counsel for a disabled prisoner pursuing Eighth Amendment, First Amendment, Americans with Disabilities Act, Rehabilitation Act, and related California state law claims. This matter is ongoing.","searchable_name":"Mark Zambarda","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null}]}}